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Preface 
The following dissertation was written by the author. The INTRODUCTION is based on an updated 
version of a previous review (Oettinghaus et al., 2012). 
The RESULTS section of this dissertation consists of a manuscript written by the author that will 
shortly be submitted for publication. Please refer to the author contributions section of the manuscript 
where the contribution of each co-author to this work is listed. 
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Abstract 
Due to their high energy demand, their highly polarized nature and the sheer length of their processes, 
neurons - more than any other cell type - depend on a well-balanced dynamic mitochondrial network. 
Drp1, the only known mammalian mediator of mitochondrial fission, is essential for neuronal 
development. Apart from studies in Purkinje cells, not much is known about the role of Drp1 in the 
postnatal brain. Tamoxifen-inducible Drp1 ablation in the forebrain leads to a swollen, perinuclearly 
aggregated mitochondrial phenotype and mitochondrial depletion from synapses resulting in impaired 
synaptic transmission. In contrast to Drp1-ablated neuronal cultures however, dendritic morphology 
and synapse numbers are not affected; however, Drp1-ablated neurons show an increased sensitivity 
to ischemia. Forebrain-specific Drp1-ablated mice also develop a complex metabolic phenotype 
characterized by weight loss, increased lipolysis and elevated corticosterone levels. Investigating this 
catabolic shift we found evidence for the activation of the unfolded protein response pathway (UPR) 
and altered ER morphology in Drp1-ablated brain regions, culminating in the induction of the 
multifaceted metabolic cytokine Fgf21. Fgf21 is normally produced in liver, fat and skeletal muscle in 
response to metabolic stress as fasting or exercise. It increases insulin sensitivity, regulates lipolysis in 
adipocytes and stimulates corticosterone production via receptors in the hypothalamus, thus 
explaining essential aspects of the observed catabolic phenotype. In summary, our results show that 
brain tissue can signal metabolic stress via Fgf21 induction, which induces a systemic metabolic shift. 
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1 
Introduction 
Mitochondria play important roles in life and death of eukaryotic cells, providing most of the ATP 
required for metabolic cell processes via oxidative phosphorylation. Moreover, in addition to regulating 
several other metabolic pathways, such as Krebs cycle, fatty acid metabolism, gluconeogenesis, and 
haem-synthesis, mitochondria also control intracellular calcium signaling and apoptosis.  
Although early, high-resolution electron microscopy images of the organelles - which were obtained by 
Palade in the early fifties and which have since coined the standard depictions for ensuing text book 
generations - displayed static, bean-shaped mitochondrial units (Palade, 1953), observations of living 
cells dating back to 1914 had already revealed that mitochondria are extremely dynamic organelles, 
modulating their morphology through fusion and fission processes that create highly interconnected 
tubular networks as well as punctiform solitary organelles (Lewis and Lewis, 1914). Research efforts 
during the last decade have deciphered the basic molecular mechanisms governing mitochondrial 
fusion and fission.  
Mitochondrial fusion  
For lipid bilayer fusion, membranes must first aggregate by coming into nanometer proximity. In order 
to approximate further to Ångstrom distance they need to overcome the negative charges of the 
outward facing sulfate groups of the hydrophilic phospholipid heads of the lipid bilayer. For this to 
happen, membranes need to be dehydrated and negative charges of hydrophilic phospholipid heads 
need to be neutralized. The two membranes to connect via a hemifusion state in which the 
components of the two lipid bilayers can mix while their lumen is not yet connected. At one point this 
hemifusion state may destabilize resulting in the formation of a fusion pore, and the lumen of both 
bilayers may join. In biological membranes the fusion process is mediated by proteins. The SNARE 
protein family is the best-studied membrane fusion-mediating protein family. SNARE proteins consist 
of a transmembrane domain and a cytosolic domain which participates in the formation of SNARE 
complexes which form between two SNARE proteins of opposing membranes and cytosolic proteins 
sharing similar protein domains. Several models exist that postulate a role for SNARE complexes in 
the formation of the hemifusion state and the formation of subsequent fusion pores (Söllner, 2003). 
The continuous changes in mitochondrial morphology are controlled by a group of evolutionary 
conserved large GTPases that share structural homology with prototypical dynamins (Smirnova et al., 
1998). Dynamins, ranging in size between 70-100 kDa, are mechanochemical enzymes that - through 
GTP hydrolysis-driven assembly into multimeric spirals around the collars of invaginating vesicles - are 
mainly involved in the scission of nascent endo- and exocytic vesicles (van der Bliek, 1999; Morlot and 
Roux, 2013). In mammals, Mitofusin 1 and 2 (Mfn1/Mfn2) are dynamin-like GTPases that regulate 
fusion of the outer mitochondrial membrane (OMM). Both proteins are anchored in the OMM and 
share structural homology, given by a cytoplasmatic N-terminal GTPase domain, two hydrophobic 
heptad repeats and two C-terminal transmembrane domains connected by a very short loop domain 
located in the intermembrane space (IMS). Mfn1 is primarily expressed on the OMM while Mfn2 is also 
expressed on the endoplasmic reticulum (ER) installing trans-organelle connections (de Brito and 
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Scorrano, 2008). The biophysics of membrane fusion mediated by mitofusins are not clear and it is 
unknown whether they only participate in the approximation of two membranes or if they also facilitate 
the formation of a hemifusion state and membrane pore formation. Opa1, another dynamin-related 
protein with eight known alternative splicing-derived isoforms in humans, is embedded in the inner 
mitochondrial membrane (IMM) through a transmembrane domain that resides nearby the N-terminus 
and protrudes the major portion into the IMS. The two non-interrelated functions of Opa1 consist in 
promoting Mfn1-mediated mitochondrial fusion as well as in regulating the intrinsic apoptotic pathway 
by impairing cristae maintenance and cytochrome c release. Therefore, it is comprehensible that Opa1 
downregulation not only leads to enhanced mitochondrial fragmentation, but also to an altered 
structure of the cristae. Interestingly, the above-mentioned splicing variants of Opa1 give rise to either 
membrane bound long isoforms or solube short isoforms that are released into the IMS. It has been 
demonstrated that tightness of cristae junctions correlates with the oligomerization of these two forms 
of Opa1 (Cipolat et al., 2006; Frezza et al., 2006). Fusion events can be divided into two categories: 
(1) those in which the OMM of two mitochondria only enter a hemifusion state and separate again 
shortly thereafter and (2) complete fusion events, where OMM and IMM fuse entirely and mitochondria 
form a syncytium. The number of complete fusion events greatly depends on Opa1 expression levels. 
This suggests that Opa1 is of particular importance for IMM fusion (Liu et al., 2009).  
Mitochondrial fission 
Membrane fission in the eukaryotic cell occurs mainly during membrane vesicle trafficking, 
mitochondrial dynamics and cytokinesis. This involves firstly the deformation of the membrane into 
spherical or tubular buds as exemplified by the formation of clathrin-coated pits in endocytosis 
(Cocucci et al., 2012) and ER tubule outgrowth (English and Voeltz, 2013). This step needs to be 
followed by the mechanical membrane constriction until a luminal contact point between two opposing 
membrane sites is established. From here on the reverse mechanistic principles apply as in 
membrane fusion, and final fission is achieved via the formation of a hemifission state. Membrane 
constriction of clathrin-coated pits is performed by dynamins and several models of the biophysics 
responsible for final membrane fission are currently being evaluated (Morlot and Roux, 2013). During 
cytokinesis membrane fission is mediated via the constriction of an intracellular, constrictive ring 
composed of actin and myosin filaments and final fission is mediated by SNARE proteins (Glotzer, 
2005).  
Dynamin-related protein 1 (Drp1) is the only known protein actively mediating mitochondrial fission. In 
humans, Drp1 is highly expressed in tissues with particular energy demands, such as brain and 
muscle, whereas moderate to low expression levels are found in liver, lung, placenta, kidney, and 
pancreas (Smirnova et al., 1998). The molecular structure of Drp1 largely corresponds to that of other 
proteins of the dynamin superfamily, except for the lack of the C-terminal proline-rich domain termed 
pleckstrin homology domain (PH) present in most members of the superfamily which is important for 
dynamin-membrane interactions (Figure 1) (Chang and Blackstone, 2007). On the cellular level, 
almost the entire Drp1 pool is cytosolic with only about 3% of the total protein content residing at the 
mitochondrial surface. In order to induce organelle fission, cytosolic Drp1 requires activation and 
subsequent translocation to the OMM. Here, Drp1 oligomers form ring-like multimeric structures on  
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Figure 1  Molecular regulation of 
Drp1-mediated mitochondrial fission 
(A) Activation of Drp1 by e.g. calcineurin-
mediated dephosphorylation targets the 
protein to mitochondria where it is 
thought to bind one of the adaptor 
proteins Mff, Mid49 or Mid51. (B) 
Additional posttranslational Drp1 
modifications such as ubiquitination and 
SUMOylation stabilize Drp1 on the 
OMM. (C) Following oligomerization, 
Drp1 assembles into constrictive ring-like 
multimers that, upon GTP hydrolysis, 
mediate membrane constriction. 
 
 
prospective OMM fission sites through a self-assembling process (Ingerman et al., 2005), followed by 
GTP hydrolysis-driven conformational changes that – via ring constriction - lead to membrane severing 
and subsequent organelle division (Lackner et al., 2009; Mears et al., 2011) (Figure 1C). Accordingly, 
integration of mutated Drp1 molecules (e.g. of the K38A mutation with incapacitated GTP hydrolysis) 
into the ring-like Drp1 multimers inhibits their constriction through dominant-negative effects, resulting 
in blocked organelle fission (Smirnova et al., 1998) (Figure 2). Membrane constriction driven by Drp1 
structurally closely resembles constriction driven by dynamin. There are a few structural differences 
that are of major importance. Prototypic dynamin possesses a PH domain which allows it to directly 
bind to membranes whereas Drp1 does not have a similar domain. In the cryo-EM reconstruction of 
polymerized Drp1 a gap of 3-4 nm between the assembled Drp1 molecules and the underlying 
membrane can be appreciated (Mears et al., 2011). It therefore appears likely that Drp1 recruitment to 
mitochondria requires an adaptor protein to attach to the OMM. Dynamin mediates the constriction of 
25 nm membrane tubules to 10 nm in vitro. These measurements match the size of the membrane 
neck of clathrin-coated pits, and the final membrane scission could be driven by shear force. Drp1 
however drives the fission of 110 nm tubules and constricts them to 35 nm. The diameter of a 
mitochondrial tube on the other hand is as large as 500 nm and a 35 nm gap between two membranes 
makes a spontaneous membrane separation unlikely (Bui and Shaw, 2013). Structural evidence 
therefore suggests that other mechanisms initiate and complete mitochondrial membrane fission 
upstream and downstream of Drp1. Preceding Drp1 recruitment, ER tubules have been observed to 
wrap around potential mitochondrial fission sites (Friedman et al., 2011), a phenomenon termed ER-
associated mitochondrial division (ERMD). Drp1 recruitment is also known to be F-actin dependent 
(DuBoff et al., 2012; De Vos et al., 2005); recently, it was shown that the ER membranes wrapping 
around mitochondrial fission sites are enriched in inverted formin 2 (INF2) which recruits actin to 
polymerize between the ER and the mitochondrial membrane (Korobova et al., 2013). Lately also 
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myosin was shown to participate in ERMD (DuBoff et al., 2012; Korobova et al., 2014). This growing 
body of evidence suggests that mitochondrial fission is initiated by the ER and driven by the 
constriction of actin and myosin filaments until the mitochondrial tubule is narrow enough for Drp1 
polymerization. The final fission from a 35 nm to a 10 nm tubule could be driven by a member of the 
dynamin family that mediates fission of other cellular membranes in this range. Another theory 
involves the modulation of the fission range of Drp1 by an adaptor molecule. Drp1 recruitment to the 
mitochondria requires an adaptor protein integrated into the OMM. Three mammalian adaptor proteins 
have been identified so far - Mid49, Mid51 and Mff – all of which can mediate Drp1 recruitment and 
mitochondrial fission on their own (Losón et al., 2013; Otera et al., 2010; Palmer et al., 2013; Richter 
et al., 2014; Zhao et al., 2009). Interestingly, in concert with Mid49, Drp1 increases the minimal 
membrane fission diameter from 35 nm to 14 nm in vitro (Koirala et al., 2013), which indicates that 
adaptor proteins are needed to drive final membrane division. In yeast, Fis1  is the only adaptor for 
Drp1. The mammalian paralogue Fis1 does only exert little fission activity which might be cell type-
specific (Losón et al., 2013; Otera et al., 2010; Shen et al., 2014). Recently, Fis1 has been proposed 
to form a complex with Drp1 and Mff and to be indispensable for mitophagy (Gomes and Scorrano, 
2008; Shen et al., 2014). 
At the moment, it is completely unclear how fission of the IMM is achieved. Maybe, in the future, an 
inner mitochondrial fission machinery will be discovered that is similar to the ftsZ rings driving bacterial 
and chloroplastic division. Interestingly, mitochondrial DNA molecules localize to Drp1- and Mff-
marked fission sites, and their distribution is Drp1-dependent (Ban-Ishihara et al., 2013) suggesting 
that the OMM fission complex is connected to the mitochondrial matrix. This leads to the speculation 
that the entire mitochondrial fission machinery is in fact a large complex spanning the ER and both 
mitochondrial membranes thus connecting cytosol and mitochondrial matrix.  
Posttranslational Drp1 modifications 
Changes in mitochondrial shape are tightly coupled to essential organellar and cellular functions, as 
exemplified during mitosis, when the balance between fusion and fission temporarily shifts towards 
fission to enable equal mitochondrial distribution to daughter cells (Taguchi et al., 2007). In order to 
allow for rapid adaptation to continuously changing cellular needs, extensive posttranslational 
modifications such as phosphorylation, SUMOylation and ubiquitination are in place which, by 
regulating the activity of mitochondrial morphogenic proteins, directly impinge on organelle 
morphology (Figure 2). When activated by increased cAMP levels, protein kinase A (PKA) 
phosphorylates Drp1 at residue S637, thereby inhibiting its GTPase activity as well as intermolecular 
Drp1 interactions resulting in elongated mitochondria (Cereghetti et al., 2008; Chang and Blackstone, 
2007; Cribbs and Strack, 2007). This mechanism is being exploited during starvation where 
mitochondrial elongation resulting from PKA-mediated Drp1 phosphorylation can protect starving cells 
from autophagy (Gomes et al., 2011). PKA-mediated Drp1 phosphorylation at S637 is counteracted by 
calcineurin, whose activation leads to organelle fragmentation by boosting Drp1 translocation to 
mitochondria (Cereghetti et al., 2008; Wang et al., 2011b). As calcineurin activation occurs in 
response to increased cytosolic Ca
2+
 levels, this mechanism could be activated in Ca
2+
-mediated 
neuronal injury, e.g. during ischemia or excitotoxicity. Of note, increased calcineurin activity and  
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Figure 2  Drp1 structure and posttranslational modifications 
Drp1 is composed of a N-terminal GTPase domain, a middle domain and a C-terminal 
GTPase effector domain (GED), the latter - through impacting GTP hydrolysis - influencing 
Drp1 oligomerisation. The K38A mutation alters catalytic core residues within the GTPase 
domain; however, K38A mutant Drp1 can still oligomerize with wildtype Drp1, thus acting as 
a dominant-negative mutation. The E3-ligases March5 and parkin can ubiquitinate Drp1 at 
currently unknown sites. March5 mediated k63-linked ubiquitination stabilizes the 
mitochondrial Drp1 pool while parkin-mediated k48-linked ubiquitination targets Drp1 for 
proteasomal degradation. Phosphorylation of Drp1 can exert either activating or inactivating 
effects. Drp1 phosphorylation at S616 by the CDK1/CyclinB complex triggers Drp1-mediated 
mitochondrial fission during mitosis. In contrast, PKA mediated phosphorylation at S637 
inhibits mitochondrial Drp1 translocation; this effect can be antagonized by the phosphatase 
calcineurin. SUMO-1-ylation of Drp1 can occur at multiple sites between the middle and 
GED domains, and is mediated by various SUMO-1 ligases such as Sumo1, Ubc9, and 
MAPL. Removal of SUMO1 is performed by the SUMOprotease SenP5. SUMO-1-ylation of 
Drp1 stabilizes its association with mitochondria while SUMO-2/3-ylation stbilizes the 
cytosolic location of Drp1. SUMO-2/3-ylation occurs at an unknown site of Drp1 by unknown 
SUMO-2/3 ligases during ischemia. Removal of SUMO-2/3 is mediated by SenP3. 
Mitochondrial fission in the context of Alzheimer`s disease involves Aβ-mediated S-
nitrosylation of Drp1 at position C644 which activates Drp1. Lastly O-linked-N-acetyl-
glucosamine glycoslysation of Drp1 at T585 and T586 occurs in cardiomyocytes and 
mediates mitochondrial fission. 
 
subsequent mitochondrial fission have been shown to participate in neuronal toxicity in a Huntington 
disease mouse model (Costa et al., 2010). 
During mitosis, Drp1 phosphorylation at S616 also activates Drp1, triggering mitochondrial fission to 
enable even mitochondrial distribution to cellular progeny. This phosphorylation event is mediated by 
the Cdk1/CyclinB complex under the control of the small Ras-like GTPase RALA and its effector 
RALBP1 (Kashatus et al., 2011; Taguchi et al., 2007). Although cell-cycle coupled events are 
obviously less significant in postmitotic cells, increased levels of Drp1 S616 phosphorylation were 
recently found in Alzheimer’s disease-affected brains (Wang et al., 2009). In postmitotic neurons, the 
S616 site can alternatively be phosphorylated by protein kinase C δ (PKCδ) in vitro as well as in vivo, 
as demonstrated in a rat model where hypertensive encephalopathy was shown to be associated with 
mitochondrial fission, accompanied by increased Drp1/PKCδ interactions on mitochondria (Qi et al., 
2011). 
6 
In addition to the various phosphorylating posttranslational modifications discussed above, Drp1 is 
subject to ubiquitination. k48-linked ubiquitination marks proteins for proteasomal degradation and 
ubiquitin-polylinkage at residue k63 is proteasome-independent. To date, MARCH5 as well as parkin 
have been shown to act as E3 ligases with substrate specificity to Drp1. However, MARCH5-
mediated, k63-linked ubiquitination stabilizes Drp1 on mitochondria (Karbowski et al., 2007; Park et 
al., 2010), while parkin-mediated, k48-linked ubiquitination promotes the proteasomal degradation of 
Drp1 (Wang et al., 2011a).  
SUMOylation of Drp1 is mediated by the small ubiquitin modifier (SUMO). Three different variants of 
SUMO exist. SUMO-1 and SUMO-2/3 share only 50% sequence homology while SUMO-2 and 
SUMO-3 differ by just three N-terminal amino acids. SUMO-1 linkage stabilizes Drp1 on mitochondria, 
thereby supporting mitochondrial fragmentation. SUMOylation of Drp1 is performed by the SUMO 
ligases Sumo1, Ubc9 and MAPL (Braschi et al., 2009; Figueroa-Romero et al., 2009; Harder et al., 
2004; Wasiak et al., 2007; Zunino et al., 2009), while deSUMOylation is mediated by the SUMO 
protease SenP5 (Zunino et al., 2007, 2009). SUMO-2/3 conjugation of Drp1 stabilizes its cytosolic 
location during ischemia. SUMO protease SenP3 activity is necessary for the removal of SUMO-2/3 
conjugates of Drp1 (Guo et al., 2013a). 
Another posttranslational modification has been identified in an Alzheimer`s disease (AD) context. S-
nitrosylation at residue C644 in AD brains promotes mitochondrial fission (Cho, Nakamura et al. 2009; 
Wang, Su et al. 2009; Nakamura, Cieplak et al. 2010).  
This multitude of different posttranslational Drp1 modifications is complemented by the discovery of 
two O-linked-N-acetyl-glucosamine glycosylation (O-GlcNAcylation) sites in cardiomyocytes: T585 and 
T586. O-GlcNAcylation of Drp1 activates its translocation to mitochondria (Gawlowski et al., 2012). 
Non-mitochondrial roles of Drp1 
Apart from promoting mitochondrial fission Drp1 has been shown to participate in the maintenance of 
other cellular organelles. Drp1 has been shown to also regulate peroxisomal fission in mammals (Koch 
et al., 2003; Wakabayashi et al., 2009; Waterham et al., 2007) dependent on the Drp1 adaptor 
proteins Fis1 and Mff (Delille and Schrader, 2008; Gandre-Babbe and Bliek, 2008; Koch et al., 2005). 
Even a role for Drp1 in vesicle trafficking of the Golgi complex could be shown for some cell lines 
(Bonekamp et al., 2010). Drp1 has also been shown to localize to the ER (Pitts et al., 1999). In β cells 
treatment with free fatty acids induces the fusion of ER tubules to ER cisternae, a process which is 
dependent on Drp1 (Wikstrom et al., 2013). Drp1 has also been implicated in highly specialized fission 
processes in the plasma membrane. In hippocampal neurons it has been shown that Drp1 is recruited 
probably via Mff to clathrin-coated pits that are retrieving transmitters from the synaptic cleft, and loss 
of Drp1 function leads to misshaped synaptic vesicles (Li et al., 2013). These results suggest that 
membrane shaping proteins may not be as specialized as previously thought and that they have 
evolutionarily adapted to modulate a variety of cellular membranes, probably in a cell type-specific 
manner.  
Drp1 has been found to be subjected to alternative splicing and different isoforms are expressed in 
different tissues, but no specialized functions could previously be assigned to different Drp1 isoforms. 
Lately, specialized isoforms have been identified that bind to microtubules and apparently aid in their 
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stabilization. Their association with microtubules is regulated in a cell cycle-dependent manner via 
phosphorylation of S616 (Strack et al., 2013). Strikingly, it seems that Drp1 not only has the ability to 
polymerize around membrane stretches but also to polymerize around fibrillar protein structures. 
Possibly, the microtubular localization of Drp1 serves to attach mitochondria to the cytoskeleton 
(Ferraro et al., 2011; Varadi et al., 2004; Yoon et al., 1998). 
Drp1 in neuronal morphogenesis, homeostasis, and neurodegeneration 
It is a well-known fact that most neurodegenerative diseases occur sporadically, with age being the 
most significant risk factor. Remarkably, more than one third out of 106 genes that have so far been 
linked to neurodegenerative diseases, are key regulators of mitochondrial function (Schon and 
Przedborski 2011). Mutations in two of the mitochondria-shaping proteins have been causally linked to 
familial neurodegenerative diseases. Whereas autosomal-dominant Mfn2 mutations are pathogenically 
underlying Charcot Marie Tooth Disease type 2A (CMT2A), a peripheral axonal neuropathy, Opa1 
mutations lead to autosomal-dominant optic atrophy (ADOA) (Westermann, 2010). In addition, the 
mitochondrial fission protein Drp1 can sporadically be affected by mutations in humans, as exemplified 
by the report of a lethal syndromic birth defect attributable to a heterozygous Drp1 mutation 
(Waterham et al., 2007). In this case, a newborn presented clinically with truncal hypotonia and 
insufficient-to-absent optic and motor reflexes accompanied by persistent lactic acidemia; the infant 
died at day 37 after birth. Workup of that case revealed marked microcephaly, abnormal brain 
development with abnormal gyral patterns as well as optic atrophy. This severe developmental 
phenotype hinted – for the first time – at a crucial role of Drp1 in brain development. Given the early 
embryonic lethality of mice genetically ablated for the mitochondrial fusion proteins Mfn1, Mfn2 (Chen 
et al., 2003) as well as of constitutive Drp1 knockout mice (see below), it seems plausible that Drp1 
mutations may cause early embryonic lethality in humans as well, with a high chance of going 
undetected in clinical practice. The importance of Drp1 for neuronal development has recently been 
confirmed beyond doubt by two murine models of genetic Drp1 ablation, each resulting in early 
embryonic lethality (E11.5). Drp1-ablated embryos display pronounced defects in organ development 
affecting liver, heart and the neural tube, and lack the trophoblast giant cell layer (Ishihara et al., 2009; 
Wakabayashi et al., 2009). Both groups were able to generate neuronal-specific Drp1 knockout mice 
using different approaches. In both models, murine embryos seem to develop normally, but die at 
postnatal day 0. Employing the engrailed1 (EN1) promoter, Wakabayashi and coworkers ablated Drp1 
specifically in the midbrain and the cerebellum, which appeared smaller, devoid of lobar structures, 
and showed decreased numbers of Purkinje neurons containing fewer mitochondria (Wakabayashi et 
al., 2009). Ishihara et al. ablated Drp1 pan-neurally using the nestin promoter, which normally gets 
activated at around day E9.5 (Ishihara et al., 2009). At E18.5, a reduction of forebrain size with white 
matter hypoplasia and periventricular leukomalacia was observed, accompanied by markedly enlarged 
subdural and ventricular spaces. In addition, hypoplasia of brain stem and cerebellum was noted. 
Further analyses revealed significantly increased numbers of TUNEL-positive neurons in deep cortical 
layers. Interestingly, Drp1 is highly expressed in layer V of the adult mouse neocortex (Belgard et al., 
2011), roughly correlating with the many TUNEL-positive cells at the cortex-white matter junction of 
Drp1-ablated mice (Ishihara et al., 2009). On the cellular level, it is interesting to note that neurons 
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express mitochondria-shaping proteins at particularly high levels, which very likely reflects the peculiar 
morphological and biochemical characteristics of this highly ATP-dependent cell type. In vitro, 
expression of the dominant-negative Drp1 mutant K38A in rat hippocampal neurons reduces the 
number of dendritic spines, underscoring again the importance of Drp1 for neuronal morphogenesis (Li 
et al., 2004) (Figure 3C). In line with these observations, mixed neuronal cultures derived from nestin-
Cre Drp1 knockout mice also feature decreased synapse formation and exhibit decreased neurite 
numbers (Ishihara et al., 2009) (Figure 3C), whereas in postnatal cortical mouse neurons Drp1 
downregulation or expression of a dominant-negative Drp1 mutant causes cell death (Uo et al., 2009). 
Also activity-stimulated formation of excitatory synapses is blocked by expression of dominant-
negative Drp1 mutants, whereas synapse formation is potentiated by the expression of wildtype Drp1 
(Li et al., 2004). Interestingly, in Alzheimer disease brains, Mfn1, Mfn2, Opa1 and Drp1 are 
simultaneously down regulated and this state seems to be associated with perinuclear mitochondrial 
aggregation and decreased numbers of dendrites and synapses (Wang et al., 2009). Lastly, it should 
be noted here that synapses in Drosophila Drp1 mutants are largely devoid of mitochondria, 
apparently without synapse function impairment. However, significant defects in the ATP-dependent 
recruitment of reserve pool vesicles exist, indicating that mitochondria present in the synaptic 
compartment are required to satisfy sustained local energy needs (Verstreken et al., 2005). 
Mitochondria are abundant at synapses (Rowland et al., 2000) as well as within the active growth 
cones of developing neurons (Morris and Hollenbeck, 1993). As will be discussed later, mitochondrial 
trafficking is an energy-dependent process that requires appropriate morphology and function of the 
organelles. Mitochondria in neurons lacking functional Drp1 tend to aggregate in the perikarya 
(Ishihara et al., 2009; Li et al., 2004; Uo et al., 2009) (Figure 3C). In developmental models, the 
neuronal demise that follows the inactivation of Drp1 seems to be largely dependent on impaired 
synapse formation and neurite outgrowth, both of which can probably, at least in part, be attributed to 
mitochondrial trafficking problems. Curiously, the mitochondrial phenotypes that can be observed in 
neurons with reduced Drp1 activity are not uniform, ranging from an elongated organelle network that 
branches out into neurites (Figure 3B) to aggregated perinuclear mitochondrial accumulations (Figure 
3C). 
This phenotypic variability seems to depend on specific experimental conditions, and especially on the 
time between Drp1 ablation and mitochondria visualization. A number of publications describe an 
elongated mitochondrial network that branches out into neurites as depicted in Figure 3B. Of note, the 
time of mitochondria visualization after Drp1 inactivation was indicated with 2-5 days (Barsoum et al., 
2006), 2-4 days (Meuer et al., 2007; Yuan et al., 2007) or 18-24h (Han et al., 2008), respectively. The 
publications describing an aggregated perinuclear mitochondrial morphology specify the time between 
Drp1 inactivation and visualization as 4 days (Li et al., 2004), 5 days (Uo et al., 2009), 9 days (Ishihara 
et al., 2009) or 20 days, respectively (Kageyama et al., 2012).  
It is thus tempting to speculate that the elongated mitochondrial morphology branching into neurites 
and dendrites (Figure 3B) represents a transient state that can be observed shortly after functional 
Drp1 inactivation, whereas the perinuclear mitochondrial clustering associated with degeneration of 
neuronal processes (Figure 3C) may result from long-term Drp1 deprivation. 
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Figure 4  Mitochondrial phenotypes in fission-incompetent neurons  
(A) Different mitochondrial phenotypes have been reported for Drp1-deficient neurons. 
Wildtype mitochondrial morphology is characterized by evenly-distributed organelles in the 
axonal, neuritic and perikaryon compartments. (B) Following functional Drp1 inactivation in 
neurons an elongated mitochondrial morphology that branches out into the neurites can be 
observed; under these conditions, mitochondria do not fragment during apoptosis and are 
protected from cell death (Barsoum et al., 2006; Cheung et al., 2007; Costa et al., 2010; 
Dagda et al., 2008; Grohm et al., 2012; Meuer et al., 2007; Park et al., 2011; Tian et al., 
2009; Young et al., 2010; Yuan et al., 2007; Zhang et al., 2013). (C) Others found impaired 
mitochondrial trafficking with elongated organelles aggregating within the perikaryon, 
accompanied by decreased numbers of neurites and synapses (Ishihara et al., 2009; Li et 
al., 2004; Uo et al., 2009). 
 
A recent report has studied the effects of neuronal Drp1 ablation in Purkinje cells and confirmed this 
assumption. Transgenic mice with a floxed Drp1 locus were crossed with mice expressing Cre 
recombinase under the control of the L7 promoter which is active in Purkinje cells 3 weeks after birth. 
In Purkinje cells of one-month-old mice the mitochondrial network appeared at first elongated, 
whereas in two-month-old mice it appeared aggregated, which finally leads to Purkinje cell 
degeneration within the first three months of age (Kageyama et al., 2012). 
Drp1 and aberrant mitochondrial trafficking in neurons 
Neurons as the longest human cells exceeding lengths of one meter in certain motor- and sensory 
neurons are especially dependent on a proper mitochondrial distribution. Distinct long- and short-
distance mitochondrial transport mechanisms exist in order to satisfy the particularly high local energy 
demands at synapses and nodes of Ranvier. Significantly, aberrant mitochondrial trafficking is likely 
the primary cause underlying the CNS developmental defects including perturbed synapse formation 
in Drp1 knockout mice. In neurons, microtubule tracks are used as long-distance transport rails to 
cargo membrane vesicles and cellular organelles including mitochondria. Axonal transport of 
mitochondria is bidirectional and thought to be coordinated with neuronal outgrowth (Morris and 
Hollenbeck 1993). Whereas anterograde (i.e. synapse-bound) cargo movement is mediated by 
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kinesins, dynein/dynactin act promiscuously in retrograde (i.e. perikaryon-bound) organelle transport. 
The protein couple Miro/Milton, acting in concert with kinesins, is responsible for anterograde 
mitochondrial trafficking, with Ca
2+
 binding Miro being anchored to the OMM. In a calcium-unbound 
state, Miro binds to Milton, which in turn can bind to kinesin motorproteins. Upon exposure to high 
calcium levels, as they occur e.g. within the pre- or postsynaptic compartments, the molecular 
Miro/Milton interaction gets disrupted, releasing mitochondria (Schwarz, 2013) The only mitochondria-
shaping protein so far directly implicated in this process is Mfn2, which interacts with the Miro/Milton 
complex (Misko et al., 2010). The multimeric dynein complex comprising dynactin and its subunit 
p50/dynamitin is responsible for retrograde mitochondrial transport. Interestingly, mitochondrial Drp1 
foci colocalize with microtubules (Varadi et al., 2004; Yoon et al., 1998). Disruption of the dynein 
complex or expression of the Drp1 K38A mutant interrupt Drp1/microtubule colocalization, thereby 
blocking mitochondrial transport (Varadi et al., 2004). Collectively, the available evidence strongly 
points to a co-dependence of Drp1 and dynein for long-distance mitochondrial trafficking, which is of 
obvious importance in highly polarized neurons. Short-distance mitochondrial transport in synapses is 
mediated by actin filaments. In analogy to the disruption of dynein complexes, disruption of actin 
filaments has been shown to attenuate mitochondrial Drp1 translocation and organelle fission (De Vos 
et al., 2005). 
Drp1 and impairment of neuronal mitochondrial quality control 
The turnover of mitochondrial material is fast and efficient . The entire mitochondrial protein content of 
a liver cell is turned over within a few days as validated in pulse-chase experiments (Lipsky and 
Pedersen, 1981). Similar experiments have not been performed in neurons; however, as these cells 
are highly efficient in clearing autophagosomes, similar rates of mitochondrial turnover can be 
expected (Boland et al., 2008). Basically, there are three different mechanisms that allow for the 
degradation of mitochondrial material. Firstly, there is the degradation of unfolded proteins by AAA 
protease complexes in the IMM (Langer et al., 2001) and the degradation of individual proteins by the 
proteasome system in the cytosol (Karbowski and Youle, 2011). Secondly, there is the formation of 
mitochondria-derived vesicles that selectively target damaged mitochondrial proteins and lipids for 
lysosomal degradation. Notably, this process is independent of Drp1 (McLelland et al., 2014; 
Soubannier et al., 2012). Thirdly, there is the targeted digestion of entire mitochondria through 
mitophagy, a specialized form of autophagy. Double membrane layered structures that are marked by 
the microtubule-associated light chain 3 protein (LC3) engulf cytosolic membrane structures including 
entire cellular organelles and fuse with lysosomes to form autolysosomes. In healthy mitochondria, 
PTEN-induced kinase 1 (PINK1) is readily imported into the IMM where it is degraded by the 
rhomboid-like protease PARL. In depolarized mitochondria PINK1 import is blocked at the OMM and 
PINK1 is able to recruit the ubiquitin ligase parkin to the OMM by phosphorylation (Narendra et al., 
2008, 2010). Mitochondrially recruited parkin in turn ubiquitinates mitochondrial proteins, among them 
Mfn2 and Miro. The ubiquitination on the OMM is detected by p62 which serves as an adaptor for LC3 
and targets mitochondria for autophagosomal engulfment (Ashrafi and Schwarz, 2013).  
Upstream of mitophagy, Drp1-mediated fission is needed to reduce the size of the mitochondria. 
Expression of mutant Drp1 is able to block mitochondria removal (Arnoult et al., 2005). Moreover, it 
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has been shown that Drp1-mediated fission can give rise to depolarized single mitochondrial units that 
subsequently undergo mitophagy (Twig et al., 2008). In line with this fundamental observation, Drp1 
ablation leads to an accumulation of oxidized proteins in mitochondria (Parone et al., 2006; Twig et al., 
2008). The Drp1 receptor Fis1 has also been found to be essential for the trafficking of mitochondria to 
autophagosomes (Gomes and Scorrano, 2008) and just recently it was shown that lack of Fis1 leads 
to the accumulation of bulk vesicles containing LC3-positive mitochondrial and ER membranes which 
led to the speculation that components of the ERMD fission complex are needed for the removal of 
mitochondrial autophagosomes (Shen et al., 2014). Lately, the physiological relevance of parkin-
mediated targeting of depolarized mitochondria for mitophagy has been questioned, because this 
phenomenon has so far only been observed after artificially induced uncoupling of mitochondria in 
vitro. The scarcity of mitophagic events under physiological conditions makes them a difficult 
phenomenon to observe. It is also difficult to experimentally measure mitophagic events as LC3 and 
p62 are also involved in targeting cargo other than mitochondria for the engulfment by 
autophagosomes (Ashrafi and Schwarz, 2013).  
Although mammalian neurons are greatly dependent on the expression of autophagic genes, they 
maintain a very low level of autophagosomes under basal conditions and even under starvation 
conditions, autophagosome formation is not increased (Yue et al., 2009). It is unclear which role parkin 
plays in the removal of defective neuronal mitochondria. In vivo parkin failed to translocate to 
mitochondria of dopaminergic neurons in the substantia nigra that were depolarized by a genetically 
induced respiratory defect (Laar et al., 2011). In vitro parkin also failed to translocate to neuronal 
mitochondria under standard uncoupling conditions (Sterky et al., 2011; Yu et al., 2011). In SH-SY5Y 
cells a 2-h treatment with the standard chemical uncoupler CCCP (20µM) is sufficient to translocate 
parkin to 80% of the mitochondria while in neurons a 24-h treatment under the same conditions is 
needed to translocate parkin to 20% of the mitochondria, even though CCCP treatment induces 
mitochondrial uncoupling as efficiently in neurons as in SH-SY5Y cells (Cai et al., 2012). Parkin 
recruitment to mitochondria seems to be locally restricted to the somatodendritic region while parkin-
independent removal of axonal mitochondria could also be observed (Cai et al., 2012). While parkin 
and PINK1 Drosophila null mutants show severe neuronal defects (Clark et al., 2006; Greene et al., 
2003; Park et al., 2006; Yang et al., 2006), parkin and PINK1 knockout mice are viable and have only 
subtle phenotypes (Kitada et al., 2007; Palacino et al., 2004; Zhou et al., 2007). It seems that 
compensatory mechanisms during embryonic development can compensate for a loss in either of 
these proteins. Deletion of parkin in adult dopaminergic neurons in the substantia nigra, however, 
induces neurodegeneration in this neuronal population (Shin et al., 2011). However, the authors 
contribute the neurodegeneration to the failure of parkin to ubiquitinate PARIS, an inhibitor of PGC-1α 
transcription (Shin et al., 2011). Many more functions than translocation to depolarized mitochondria 
are attributed to parkin. For example, it exerts an antiapoptotic function by impinging on NF-κB 
signaling leading to the subsequent upregulation of Opa1 (Müller-Rischart et al., 2013). It also 
ubiquitinates miro and Mfn2, stopping mitochondrial transport and fusion (Wang et al., 2011c). The 
same goes for PINK1 which, in addition to parkin, phosphorylates complex I and thereby regulates 
respiratory efficiency (Morais et al., 2009). In summary, it is unclear how mitophagy is regulated in 
neurons and the PINK1/parkin pathway might only play a minor role. Due to the scarcity of adult 
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neurogenesis, postmitotic neurons are indispensable to the organism and autophagic processes in 
these cells are under tight control by regulatory processes likely to be unique compared to other cell 
types. For example, neuronal autophagy is likely to occur only in the soma where most lysosomes are 
located, and might therefore be inhibited in other regions of the cell. 
Another aspect of mitochondria quality control is the distribution of mtDNA molecules. Single 
mitochondrial organelles carry several mtDNA copies, ensuring that intact mtDNA molecules can 
compensate for damaged (i.e. mutated) ones. It is thus believed that - via fusion of the organelles - 
mitochondria constantly exchange their mtDNA content within single cells. Proof of functionally 
important mtDNA exchange was first provided more than a decade ago through a very elegant 
approach (Ono et al., 2001): through hybridizing two cell lines each carrying one specific mtDNA 
mutation associated with respiratory deficiency, normal respiration rates could be restored (Ono et al., 
2001). In addition, experiments with mice carrying mtDNA mutations proved that, in fact, a population 
of mitochondria within one cell shares a common pool of mtDNA (Nakada et al., 2001). The process of 
mitochondrial complementation is highly dependent on organelle fusion as demonstrated in a murine 
muscle-specific Mfn2-knockout model, where mtDNA mutations accumulate at similar rates as in mice 
expressing a proof-reading defective mitochondrial DNA polymerase mutant (Chen et al., 2010). In 
wildtype cells mitochondrial mtDNA molecules locate to mitochondrial fission sites and Drp1 
downregulation leads to clustering and apparent loss of  mtDNA molecules (Ban-Ishihara et al., 2013; 
Parone et al., 2008) .This indicates, that Drp1-mediated mitochondrial fission is required for the spatial 
organisation of mtDNA. 
Drp1 in apoptosis  
Soon after Drp1`s discovery as a mitochondrial fission protein, it was observed that the mitochondrial 
fragmentation occurring during apoptosis could be inhibited by overexpression of the dominant-
negative Drp1 mutant K38A. Blocking Drp1 function not only inhibited fragmentation of the organelles 
but, more importantly, also delayed mitochondrial cytochrome c release and subsequent apoptotic cell 
death (Frank et al., 2001). However, the general necessity of mitochondrial fission for apoptosis 
remains a matter of debate largely attributable to specific experimental setups (including cell lines, 
specific stimuli, differential sensitivity of various cell death detection assays, as well as different means 
of Drp1 functional inactivation) (Sheridan and Martin, 2010; Wasilewski and Scorrano, 2009). 
We would like to restrict our discussion here to comment on the differential results reported for the 
available Drp1 knockout mouse models (Ishihara et al., 2009; Wakabayashi et al., 2009). Whereas 
Wakabayashi et al., using non-immortalized mouse embryonic fibroblasts in their cell death assays, 
did not observe a delay in apoptosis, the Mihara group using immortalized fibroblasts were able to 
show just that (Ishihara et al., 2009; Wakabayashi et al., 2009). Interestingly, complete Drp1 ablation 
did not block, yet delayed mitochondrial fragmentation during apoptosis (Ishihara et al., 2009). 
Perhaps, this effect is attributable to compensatory changes in expression levels of other mitochondria 
shaping proteins, which are already altered at steady state in Drp1 null fibroblasts (Ishihara et al., 
2009). In summary, genetic Drp1 ablation delays programmed cell death, but is not sufficient to block 
it.  
13 
On the organelle level, Drp1 has been proposed to facilitate apoptotic cell death by impinging either on 
outer mitochondrial membrane permeabilization or, alternatively, on mitochondrial cristae remodeling. 
Key mediators of OMM permeabilization are the “multidomain proapoptotics” Bax and Bak. Both 
proteins belong to the Bcl-2 family of proteins and get activated in the OMM by so-called “BH3-only” 
proteins, a Bcl-2 family subset. Once activated, mitochondria release proapoptotic factors such as 
cytochrome c into the cytosol, where subsequent activation of downstream effector caspases occurs 
via formation of the apoptosome, a specialized protein complex containing APAF1 and pro-caspase-9 
(Wasilewski and Scorrano, 2009). Of note, in healthy cells, about 85% of the soluble cytochrome c 
pool reside within the cristae compartment, made up by specialized IMM structures. During apoptosis, 
dramatic morphological changes termed cristae remodeling take place, facilitating the release of 
cytochrome c during programmed cell death (Bernardi and Azzone, 1981; Scorrano et al., 2002). 
Expression of the dominant-negative Drp1 mutant K38A can rescue cristae remodeling induced by 
overexpression of the proapoptotic Bcl-2 protein Bik (Germain et al., 2005) as well as by expression of 
 
Figure 5 Mitochondrial fission in neuronal death 
Mitochondrial fission has been implicated in the pathogenesis of several 
neurodegenerative diseases. Compounds mimicking neurotoxicity as it occurs in 
neurodegeneration have in vitro been shown to mediate neuronal death dependent on 
mitochondrial fission. Interestingly, Cdk5, implicated in the pathogenesis of several 
neurodegenerative conditions, functions as an upstream regulator of mitochondrial fission 
during neuronal apoptosis. The protein also plays a prominent role in Ca2+-mediated cell 
death pathways. Here, Ca2+-activated calpains process the p35 Cdk5 activator protein to 
yield p25, resulting in enhanced Cdk5 activity. In addition, Ca2+ can also trigger 
mitochondrial fragmentation directly by calcineurin-mediated Drp1 S637. On the organelle 
level, intramitochondrial Ca2+ accumulation may lead to organelle swelling and OMM 
rupture, opening of the permeability transition pore, culminating in the release of 
proapoptotic factors such as cytochrome c from the mitochondria into the cytosol. 
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mutant huntingtin (Costa et al., 2010). As to now, a plausible answer on how a cytosolic protein such 
as Drp1 that is targeted to the OMM, can influence cristae remodeling, is lacking. Indirect effects on 
the proteolytic processing of Opa1, a key regulator of cristae morphology, may represent a plausible 
scenario as, in fact, levels of proteolytically derived Opa1 isoforms are altered in several Drp1-ablated 
cell models (Ishihara et al., 2009; Mopert et al., 2009). During apoptosis, Bax translocation from the 
cytosol to the OMM is dependent on Drp1 and facilitated by cardiolipin, a mitochondrial lipid residing in 
the IMM. It has been postulated that, in addition to modulating cristae remodeling, Drp1 is involved in 
the formation of hemifusion sites that bring inner and outer mitochondrial membranes into close 
contact with each other, thereby enabling the exchange of lipids between the two membranes and 
facilitating Bax membrane integration (Montessuit et al., 2010). Previously Bax has been shown to 
localize to mitochondrial fission sites during apoptosis, colocalizing with Drp1 and Mfn2 (Karbowski et 
al., 2002). This mechanism could be particularly important in neurons, where nitric oxide donor–
induced translocation of Bax to mitochondria is Drp1-dependent (Yuan et al., 2007). Of note, the 
neuronal death in this model requires Drp1 and Bax but no caspase activation, exemplifying a mode of 
neuronal damage engaging certain modules of the molecular apoptosis cascade without following the 
complete pathway of classical intrinsic programmed cell death.  
Neuronal apoptosis related to changes in mitochondrial morphology has poorly been investigated so 
far. It is generally difficult to detect in vivo as cells dying by apoptosis are swiftly removed by the 
immune system. Drp1-knockout neurons, which display an aggregated mitochondrial morphology, are 
more sensitive to the pan-kinase inhibitor staurosporine (STS) as well as to ceramide, a Ca
2+
 stress 
inducing drug (Ishihara et al., 2009). In contrast, neurons transiently deprived of functional Drp1 
display an elongated mitochondrial phenotype (Figure 3B) and show resistance to various apoptotic 
stimuli such as STS (Costa et al., 2010; Meuer et al., 2007; Young et al., 2010), rotenone (Barsoum et 
al., 2006; Dagda et al., 2008), MPP
+
 (Barsoum et al., 2006), A-β peptide 25-35 (Barsoum et al., 2006), 
nitric oxide (Barsoum et al., 2006; Yuan et al., 2007), hydrogen peroxide (Cheung et al., 2007), and 
methamphetamine (Tian et al., 2009) (Figure 4). The discrepancy between these conditions of 
functional Drp1 inactivation with respect to cell death susceptibility may, as already discussed, be 
related to the timing of Drp1 ablation: whereas long-term Drp1 ablation favors neuronal death, short-
term ablation seems to exert neuroprotective effects. The lack of mitochondrial fission under 
conditions of genetic Drp1 ablation is likely compensated for by the degradation of the Opa1 protein 
along with downregulated expression of Mfn1 and Mfn2, all of which result in decreased fusion of the 
organelles (Ishihara et al., 2009; Mopert et al., 2009).  
Ca
2+ 
influx is an important inducer of neuronal death. In the context of apoptosis, increased 
mitochondrial Ca
2+ 
uptake can trigger mitochondrial permeability transition, organelle swelling with 
rupture of the OMM, culminating in the release of proapoptotic factors into the cytosol. In addition, 
Ca
2+
 activates calpains which trigger apoptosis by cleavage of the BH3-only protein Bid and by 
processing of the Cdk5 activator p35 to yield the more active p25 form (Lopes and Agostinho, 2011). 
When activated, Cdk5 mediates STS-induced caspase-dependent neuronal death that is preceded by 
mitochondrial fragmentation (Meuer et al., 2007). In summary, for neurons, currently available 
evidence suggests a tight interplay between pathways of Ca
2+
-mediated neuronal death and classical 
apoptosis that in both cases involves dysregulated mitochondrial dynamics (Figure 4).  
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Drp1 in ischemic brain damage and excitotoxicity 
Blocking of brain blood vessels by thrombosis can immediately cut off nutrient and blood supply of 
affected brain regions. Surrounding the necrotic ischemic core where neurons perish by necrosis as 
an immediate consequence of lacking nutrients, the penumbra receives reduced nutrient supply and 
remains metabolically active. Cells within the penumbra are susceptible to apoptotic cell death, which 
occurs primarily as a consequence of excitatory amino acids and proteolytic enzymes released from 
the necrotic core region. As the penumbra can make up more than half of the total infarction size and 
apoptotic pathways can be targeted with increasing success, understanding the pathophysiology of 
ischemic brain damage is imperative for the successful development of neuroprotective strategies 
targeting such socio-economically important conditions as ischemic stroke (Broughton et al., 2009). In 
murine models of cerebral ischemia mitochondria within the penumbra have been shown to fragment 
(Barsoum et al., 2006). As Drp1-mediated mitochondrial fragmentation is commonly observed early 
during apoptosis - with its inhibition delaying programmed cell death in most experimental scenarios - 
chemical inhibition of Drp1 using small molecule inhibitors has recently emerged as a promising 
therapeutic strategy. This is exemplified by mdivi-1, a Drp1-inhibiting compound (Cassidy-Stone et al., 
2008) which significantly increases neuronal survival in rodent brain ischemia models (Grohm et al., 
2012; Zhang et al., 2013) as well as in rodent retinal ganglion ischemia (Park et al., 2011). 
Remarkably, mdivi-1 is also effective in reducing infarct sizes in renal (Brooks et al., 2009) and cardiac 
ischemia (Ong et al., 2010). In this context it is interesting to note that transgenic mice overexpressing 
miR-499 show reduced myocardial infarction sizes when subjected to cardiac ischemia (Wang et al., 
2011b). miR-499 is a micro RNA targeting calcineurin (a cytosolic phosphatase which under normal 
conditions favors mitochondrial fragmentation via Drp1 dephosphorylation (Cereghetti et al., 2008)). 
During brain ischemia, SUMO-2/3-ylation is reported to globally increase in the affected brain regions 
and also to affect Drp1. SUMO-2/3-ylation prevents the translocation of Drp1 to mitochondria and 
subsequently inhibits mitochondrial fragmentation and cytochrome c release. During ischemia, the 
unfolded protein response pathway (UPR) is activated that leads to the inactivation of the SUMO 
protease SenP3, that under steady-state conditions readily removes SUMO2/3 from Drp1 which 
prevents neuronal apoptosis. Upon reoxygenation during reperfusion of the infarct area, UPR stress is 
lifted and SenP3 activity is restored, making neurons again susceptible to apoptosis (Guo et al., 
2013a). This suggests that Drp1 inhibition prior to restoring perfusion may be of utmost importance for 
the clinical treatment of stroke or myocardial infarct patients. 
In addition to limited nutrient supply, neurons within in the cerebral penumbra are exposed to extreme 
Ca
2+
-mediated excitotoxic stress. Energy depletion inhibits membrane potential maintenance with 
subsequent depolarization triggering the release of synaptic vesicles that contain excitatory amino 
acids. Moreover, excitotoxic stress induced by activation of ionotropic NMDA receptors on presynaptic 
membranes allows for Ca
2+
 influx, thereby dramatically elevating intracellular Ca
2+
 levels which - when 
exceeding the uptake capacities of the ER – may result in neuronal cell death. Sharp rises in 
mitochondrial Ca
2+
 can activate Drp1 through calcineurin-mediated dephosphorylation, and trigger 
mitochondrial permeability transition with subsequent activation of the mitochondrial gateway to 
apoptosis. In addition, Ca
2+
 influx into neurons is known to activate calpains (a class of calcium-
dependent cysteine proteases). Calpains have been shown to stimulate neuron-specific cyclin-
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dependent kinase 5 (Cdk5) forcing cell cycle reentry of postmitotic neurons and promoting neuronal 
death (Broughton et al., 2009; Lopes and Agostinho, 2011). Moreover, glutamate stimulation of 
neuronal NMDA receptors leads to reduced mitochondrial motility and fragmentation of the organelles, 
finally culminating in cell death (Jahani-Asl et al., 2011; Rintoul et al., 2003; Young et al., 2010). Of 
note, death induced by NMDA receptor-stimulated Ca
2+
 influx can be blocked by overexpression of 
Opa1 (Jahani-Asl et al., 2011) and, in vivo, by overexpression of the endogenous calpain inhibitor, 
calpastatin (Higuchi et al., 2005). Overstimulation of NMDA receptors also occurs during epileptic 
seizures. The Drp1 inhibitor mdivi-1 has been shown to limit neuronal loss during status epilepticus 
elicited by pilocarpine in a rat model (Qiu et al., 2013). 
Taken together, the currently available evidence suggests that Drp1-mediated mitochondrial fission 
contributes to neuronal cell loss under ischemic and excitotoxic conditions. Pharmacological inhibition 
of the fission machinery, e.g. by the small molecule Drp1 inhibitor mdivi-1, appears to represent a 
plausible approach that should extensively be tested for its potential as a neuroprotective therapeutic 
strategy.  
Drp1 in Alzheimer’s disease 
Clinically characterized by progressive decline of cognitive functions and memory, Alzheimer’s disease 
(AD) is a late-onset neurodegenerative disease that leads to the most common form of dementia. 
Traditional, pathological hallmark features of AD comprise the formation of neurofibrillar tangles 
composed of hyperphosphorylated tau protein, as well as senile plaques formed by aggregated 
amyloidogenic A-β-peptides derived from proteolytic cleavage of amyloid precursor protein (APP). 
During the last few years evidence has been emerging indicating that dysregulated mitochondrial 
morphology may represent an important component in the complex pathogenesis of AD. Neurons that 
either overexpress APP or are exposed to toxic A-β peptides display abnormal levels of mitochondria-
shaping proteins in association with a perinuclearly aggregated mitochondrial phenotype (Barsoum et 
al., 2006; Manczak et al., 2011; Wang et al., 2008, 2009). These findings are paralleled by studies of 
AD patient brains reporting abnormal expression levels of mitochondrial morphogenic proteins 
(Manczak and Reddy, 2012; Manczak et al., 2011; Wang et al., 2009) and mitochondria aggregated in 
the perikarya (Wang et al., 2009). Of note, specific, abnormal interactions between Drp1 and A-β have 
recently been identified in AD brains (Manczak et al., 2011). In addition, a direct interaction between 
hyperphosphorylated tau and Drp1 could be shown in AD patients as well as in two different AD 
mouse models (Manczak and Reddy, 2012). Different mouse models expressing mutant forms of tau 
feature impaired mitochondrial morphology. One model expressing inducible P301L mutant tau 
displays abnormal mitochondrial distribution in neurons but no increase in mitochondrial size 
(Kopeikina et al., 2011). In another model, mice and flies also carrying the tau P301L mutation display 
an elongated mitochondrial phenotype in their neurons; this elongation is due to actin filament 
disruption by tau which inhibits Drp1 translocation to mitochondria (DuBoff et al., 2012). It seems that 
both Drp1 overstimulation and Drp1 inhibition can lead to an AD-like phenotype. The complex interplay 
of A-β, tau and mitochondrial morphology has recently been reviewed (DuBoff et al., 2013). Lastly, 
specific posttranslational Drp1 modifications have recently been associated with AD. For example, 
increased levels of Drp1 phosphorylation at position S616 are found in AD brains (Wang, Su et al. 
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2009). Moreover, Drp1 can undergo S-nitrosylation at residue C644 in an AD context, promoting 
mitochondrial fission (Cho, Nakamura et al. 2009; Wang, Su et al. 2009; Nakamura, Cieplak et al. 
2010).  
Drp1 in Huntington’s Chorea 
A progressive monogenic neurodegenerative disorder, Huntington’s disease (HD) is inherited in an 
autosomal-dominant pattern. It is clinically characterized by involuntary movements such as chorea 
and dystonia, accompanied by psychiatric disturbances and cognitive decline leading to dementia. 
Albeit most of the patients experience initial symptoms in their midlife, HD also includes juvenile onset 
forms. On the molecular level, an intragenic CAG-triplet expansion within the huntingtin (Htt) gene on 
chromosome 4 results in an abnormal stretch of polyglutamine residues, determining age of onset and 
disease severity. Histopathological correlates include: progressive neuronal loss affecting in particular 
striatal GABAergic spiny neurons, and atrophy and gliosis in basal ganglia, cortex, and hippocampus. 
With several theories existing on the neurotoxicity of mutant Htt aggregates, the exact pathobiology of 
HD remains to be determined. Transcriptional dysregulation, defective intracellular trafficking, and 
abnormal mitochondrial bioenergetics and dynamics are all currently being discussed as pathogenic 
factors (Walker, 2007). HD-like phenotypes can easily be recapitulated in transgenic mice expressing 
full-length mutant Htt or a N-terminal Htt fragment. Pharmacological inhibition of electron transport 
chain (ETC) complex II also induced HD-like symptoms in mice indicating a strong mitochondrial 
component of the disease (Brouillet et al., 1998). Recent studies in HD patient lymphoblasts as well as 
in primary striatal neurons isolated from HD mouse models revealed a fragmented mitochondrial 
morphology in concert with an increased susceptibility to apoptotic stimuli. Additionally, increased 
calcineurin activity paralleled by dephosphorylation and association of Drp1 with mitochondria has 
been reported (Costa et al., 2010). Intriguingly, this phenotype is accompanied by changes in 
mitochondrial ultrastructure. Of note, the effects of mutant Htt on mitochondrial fragmentation can be 
rescued either by the expression of Opa1, the dominant-negative Drp1 mutation K38A, or a dominant-
negative calcineurin mutant. The fact that, unlike Opa1, expression of the mitochondrial fusion protein 
Mfn1 is unable to counteract the increased apoptosis susceptibility of mutant Htt cells emphasizes the 
importance of Opa1-dependent cristae maintenance, which provides protection from inappropriate 
cytochrome c release and ensuing apoptotic cell death (Costa et al., 2010). In addition to increased 
mitochondrial fragmentation and neuronal cell death susceptibility, impaired mitochondrial trafficking 
has also been demonstrated in mutant Htt cell lines. Mutant huntingtin binds to mitochondria, where it 
assembles into large oligomers at prospective fission sites, similar to Drp1 complexes. Apparently, the 
co-localization of Drp1 and mutant Htt at mitochondrial fission sites is based on specific Drp1/Htt 
interactions, that are much weaker in the case of wildtype in comparison to mutated Htt (Shirendeb et 
al., 2012; Song et al., 2011). In human HD brain, the occurrence of mutant Htt aggregates correlates 
well with the expression of mitochondrial fission-mediating proteins. In particular in striatal and cortical 
specimens from HD patients, mitochondrial fission genes Drp1 and Fis1 are expressed at higher 
mRNA and protein levels, whereas Opa1, Mfn1 and Mfn2 fusion proteins are decreased. Finally, an 
increased expression of mitochondrially encoded ETC genes as well as significant oxidative DNA 
damage have been demonstrated in human HD brains, once again reflecting the pathogenically 
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important relationship between mutant HTT and mitochondrial dysfunction in HD (Shirendeb et al., 
2011). Recently, a novel Drp1 inhibitor, P110-TAT, was able to relieve HD symptoms in a mouse 
model (Guo et al., 2013b), implying that HD patients may benefit from pharmacological reduction of 
Drp1 activity. 
Drp1 in Parkinson’s disease 
Parkinson`s disease (PD) is the second most common neurodegenerative disease affecting roughly 
1% of the population aged 65 years or above (von Campenhausen et al., 2005). Roughly 10% of all 
cases are associated with mutations in different PARK gene loci, the remaining cases being sporadic 
with age being the major risk factor. PD pathology is characterized by the loss of dopaminergic 
neurons in the substantia nigra pars compacta and the formation of intraneuronal inclusions known as 
Lewy bodies (LB) (Ehringer and Hornykiewicz, 1960; Fearnley and Lees, 1991). On the molecular 
level, PD pathogenesis has long been regarded as being primarily caused by mitochondrial 
dysfunction, and, more recently, also by impaired protein turnover causing accumulation of toxic 
protein aggregates. Apart from LB formation, levels of core components of the ubiquitin-proteasome 
system are decreased (St. P. McNaught et al., 2003), paralleled by an increase in autophagic 
vacuoles in PD brains (Anglade et al., 1997). Further, it has long been known that exposure to ETC 
complex I-inhibiting toxins such as 1-methyl-4-phenylpiridinium (MPP
+
), rotenone or paraquat can 
rapidly induce PD-like symptoms in humans and laboratory animals (Langston et al., 1983; Meredith et 
al., 2008). In addition, complex I deficiency (Schapira et al., 1990) and elevated reactive oxygen 
species (ROS) levels (Yan et al., 2013) are frequently observed in PD patients. Moreover, two of the 
PARK genes, parkin and pink1, play pivotal roles in the removal of damaged mitochondrial organelles 
via mitophagy (Narendra et al., 2008, 2010), and other work has identified Drp1 as one of the targets 
of the E3 ubiquitin ligase, parkin (Wang et al., 2011a). Interestingly, expression of PKA or of the Drp1 
S637D phosphomimetic mutation (this S637 phosphorylation is mediated by PKA) can revert the 
mitochondrial pro-fission phenotype of PINK1-deficient cells (Dagda et al., 2011). In addition, PINK1-
deficient cells display increased calcineurin activity; accordingly, their pro-fission phenotype can be 
reverted by treatment with the calcineurin inhibitor FK506 (Sandebring et al., 2009). α-synuclein, 
another PARK gene and major LB component (Spillantini et al., 1997), associates with mitochondria 
and induces Drp1-independent mitochondrial fragmentation (Nakamura et al., 2011) which it achieves 
by disrupting ER-mitochondria contacts (Guardia-Laguarta et al., 2014). In summary, mitochondrial 
dysfunction significantly contributes to PD pathology. To what extent dysregulated mitochondria 
morphogenesis and turnover contribute to the pathogenesis of sporadic PD remains to be elucidated.  
Aim of the thesis 
Ablation of Drp1 in developing neuronal tissue has been shown to have disastrous effects in mice and 
in humans (Ishihara et al., 2009; Wakabayashi et al., 2009; Waterham et al., 2007). This contrasts the 
beneficial effects of Drp1 ablation during neuronal apoptosis and ischemia (Barsoum et al., 2006; 
Cheung et al., 2007; Costa et al., 2010; Dagda et al., 2008; Grohm et al., 2012; Meuer et al., 2007; 
Park et al., 2011; Tian et al., 2009; Young et al., 2010; Yuan et al., 2007; Zhang et al., 2013).  
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The first aim of this thesis was to separate the role which Drp1 plays during neurodevelopment from its 
role during neuronal death in vivo. We therefore sought to ablate Drp1 in postmitotic neurons in the 
adult mouse brain when brain development is completed. We crossed transgenic mice with a floxed 
Drp1 locus (Drp1
flx/flx
) with mice expressing an inducible Cre recombinase transgene under the control 
of the CamKIIα promoter (Cre
+
) which is active in the hippocampus and the cortex of adult mice. 
Forebrain-specific Drp1 ablation would be induced when the offspring of these crosses would be 8 
weeks old and puberty and brain development completed, thereby eliminating the neurodevelopmental 
defects that occur due to constitutive Drp1 ablation. The mice would then be surgically subjected to 
ischemia and status epilepticus to test for neuroprotective effects of genetic Drp1 ablation. This 
genetic model has the advantage of restricting Drp1 ablation to neurons and not to systemically inhibit 
Drp1 in all tissues as a synthetic Drp1 inhibitor would. Furthermore, this model has the benefit of 
eliminating possible off-target effects of Drp1 inhibitors.  
The second aim of this work was to study the long-term effects of adult Drp1 ablation on neurons in 
vivo. Protocols for the genetic manipulation of primary neuronal cultures involve electroporation, 
transfection or lentiviral infection while the neurons are still not fully differentiated. Long-term Drp1 
ablation in these cultures led to a decrease in dendritic structures and synapses (Ishihara et al., 2009; 
Li et al., 2004; Uo et al., 2009). In this work we aimed to study the effect of Drp1 ablation on synapses 
and dendrites in an in vivo setting when synapse and dendrite formation are completed and neurons 
supported by glia cells. 
The third aim of this thesis was to investigate the unexpected change of metabolism that developed 
after forebrain-specific Drp1 ablation. Monitoring physiological parameters of the initial Drp1-ablated 
mouse cohorts we found that the metabolic phenotype outweighed the neurological phenotype. Part of 
this work was to systematically survey various relevant metabolic parameters during phenotype 
progression, including blood hormone measurements as well as gene and protein expression level 
analyses in various tissues.  
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Additional Results 
In order to monitor mitochondrial morphology after Drp1 ablation we electroporated primary 
hippocampal neurons derived from Drp1
flxflx
 E17 embryos with mYFP and Cre expression constructs. 
The expression of mitochondrially targeted YFP allowed us to monitor mitochondrial morphology while 
Cre expression would induce the knockout of the drp1 gene. We found that following Drp1 ablation 
mitochondria would initially become superelongated and protrude into the dendrites in large tubular 
structures. However, three days after Drp1 ablation mitochondria would start forming mitochondrial 
blebs in the perikarya and after nine days the superelongated mitochondria were collapsed and only 
large spherical mitochondria around the nuclei were detectable (Figure 5A). This observation 
confirmed our hypothesis that the discrepancies between published neuronal mitochondrial 
phenotypes were caused by the time period between Drp1 ablation and visualization of mitochondria. 
Our data clearly show that mitochondrial morphology changes progressively with time after Drp1 
ablation.  
We wanted to see whether similar mitochondrial morphology phenotypes can be observed in vivo. 
Mice with loxP sites inserted in the Drp1 gene (Drp1
flx/flx
) (Ishihara et al., 2009) were crossed with mice 
expressing a Cre recombinase fusion protein that induces recombination only after tamoxifen binding 
(Cre
+
) (Erdmann et al., 2007). The expression of the Cre transgene was under the control of the 
CamkIIα promoter limiting recombination primarily to cortex and hippocampus. At 8 weeks of age the 
offspring of these crossings were injected with tamoxifen and maximum depletion of Drp1 protein 
levels was observed in brain lysates as early as 10 days after tamoxifen administration (see 
Manuscript). We also visualized mitochondria by fluorescence microscopy of coronal cross sections of 
formalin-fixed paraffin-embedded (FFPE) mouse brains in hippocampal pyramidal neurons (Figure 
5B). We were not able to pinpoint a hyperfused mitochondrial network as in neuronal cultures but 
observed that large spherical mitochondrial units started to form in the perikarya around ten days after 
Drp1 ablation. To test whether this change in mitochondrial morphology would alter neuronal 
resistance to apoptotic stimuli we subjected 4-week-Drp1-ablated mice and their wt counterparts to 
surgically induced focal ischemia which would induce small cortical infarcts (Figure 6A); we found that 
the infarct volume in Drp1
flx/flx
 Cre
+
 mice was greatly increased (infarct volume Drp1
flx/flx
: 3.18 ±- 0.4 
mm
3
 versus Drp1
flx/flx
 Cre
+
 5.29 ± 0.63 mm
3
) (Figure 6B). We also induced status epilepticus in Drp1-
ablated mice by microinjecting kainic acid onto the hypothalamus. This model was very efficient in 
inducing neuronal cell death as exemplified in Figure 6A. Cell death was induced in almost all 
pyramidal hippocampal neurons only sparing a small population in the CA2 region (Figure 6C). We 
compared neuronal cell death along the cornu ammonis between Drp1-ablated and wt animals and 
found that this excitotoxicity model induced cell death to equal extent in both groups (Figure 6D). 
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Material and Methods 
Permanent focal ischemia 
Permanent focal ischemia was performed by electrocauterization of the middle cerebral artery (MCA) 
following craniotomy (Backhauss et al., 1992). Briefly, mice were deeply anesthetized by an i.p. 
injection of a ketamine/xylazil cocktail (10 mg/kg ketamine and 20 mg/kg xylazil). An incision in the 
scalp was made to expose the skull and the temporalis muscle. The m. temporalis was cut and a hole 
(diameter 5 mm) was drilled into the underlying skull to uncover the MCA, whose distal branches were 
subsequently electrocauterized. Three days post surgery anaesthetized mice were killed by 
transcardial perfusion with 20 ml of cold PBS followed by 20 ml of 4 % formaldehyde in PBS pH 7.4. 
Brains were dissected and post-fixed overnight. Following paraffin-embedding, 100-μm-spaced serial 
coronal cross sections were prepared and stained with cresyl violet. The infarct area of each section 
was measured and infarct volume calculated applying the Cavalieri principle. 
Immunohistochemistry 
Formalin-fixed, paraffin-embedded sections of the infarct area were deparaffinized and immersed in 
95°C citrate buffer pH 6 for 15 min. Sections were blocked with 15% normal goat serum (NGS) for 1h 
and subsequently incubated with a primary antibody for cytochrome c oxidase subunit1a (abcam 
ab14705, 1:200) and the secondary antibody mouse AF488 (Molecular Probes A11029; 1:1000). 
Slides were mounted with Prolong Gold Antifade mounting solution containing DAPI (Life 
Technologies). Z-stacks were recorded with an inverted Zeiss Axiovert 200M LSM 510 Meta confocal 
microscope with a 100x/1.4 Oil DIC objective using Enterprise 405 nm and Argon 488 nm lasers. Z-
stacks were projected onto a single plane using ImageJ. 
Cell culture 
Cortices of E17 Drp1
flx/flx
 embryos were mechanically dissected and enzymatically dissociated in 
0.25% trypsine (Life Technologies) for 10 min at 37°C. Neurons were plated on coverslips coated with 
15 µg/ml poly-L-ornithine (Sigma) in Neurobasal medium (Life Technologies), 1.25 µM glutamine, 0.1 
mM β-mercaptoethanol and 1x B27 (Life Technologies). After 48 h glia cell growth was inhibited with 5 
µM Ara-C (Sigma). Prior to plating, neurons were co-electroporated using the Neon electroporation 
system (Life Technologies). The mYFP plasmid was previously described (de Brito and Scorrano, 
2008; Cereghetti et al., 2008). pPGK-Cre was a kind gift from T. Langer (University of Cologne, 
Institute for Genetics, Department for Genetic Biochemistry, Germany). 
Figure 6  Effect of Drp1 ablation on neuronal mitochondrial morphology  
(A) Primary cortical neurons isolated from Drp1flx/flx E17 embryos: prior to seeding they were 
co-electroporated with mYFP- and Cre-expression constructs. (B) 4-week-old Drp1flx/flx and 
Drp1flx/flx Cre+ mice have been injected i.p. twice daily for 5 consecutive days with 1 mg of 
tamoxifen, and sacrificed 0-21 days after last injection. Coronal sections of formalin-fixed 
paraffin-embedded brains were immunostained for cytc oxidase subunit 1 (green) and with 
DAPI (blue). The images show pyramidal CA1 neurons. Similar abnormalities in mitochondria 
morphology were observed in dentage gyrus granule neurons. 
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Figure 7  Drp1-ablated neurons are not protected against ischemic and excitotoxic 
insults 
(A) 4 weeks after tamoxifen-treatment, Drp1flx/flx Cre
+
 and control Drp1flx/flx mice were subjected to 
permanent ligation of the distal branches of the middle cerebral artery to induce focal cortical 
ischemia. Serial coronal sectioning was performed on formalin-fixed, paraffin-embedded brains to 
measure infarct areas. Cresyl stain demonstrating ischemic infarct area in the frontal cortex. (B) 
Quantification of infarct volumes reveals statistically significant differences. Data represent mean ± 
SEM of at least 12 animals (C) 4 weeks after tamoxifen-treatment, Drp1flx/flx Cre
+
 and control 
(Drp1flx/flx) mice were stereotaxically injected into the right hemisphere with 70nl of 20 mM kainic 
acid (-1.9 mm anterioposterior, -1.5 mm mediolateral, –2.0 mm dorsoventral, bregma used as 
reference) to induce status epilepticus. Mice were sacrificed 48h after injection, and formalin-fixed, 
paraffin-embedded brains were sectioned. H&E stain demonstrates extensive neuronal damage 
ipsilateral, extending over much of the pyramidal neurons of the cornu ammonis with the exception 
of the CA2 sector in some mice (in image left). Note the healthy appearance of neurons of the 
contralateral side (right) at the time of the experiment. (D) The ratio of apoptotic (condensed) 
versus non-apoptotic nuclei was calculated across the entire length of the cornu ammonis. The 
percentages were transferred into grey values, with the maximum grey value representing maximal 
damage. Data represents mean grey values of at least 5 animals. 
The asterisk denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05 
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Induction of status epilepticus 
Status epilepticus was induced as previously described (Theofilas et al., 2009). Briefly, 4-week-Drp1-
ablated and control mice were anesthetized by continuous isoflurane inhalation and their heads were 
placed inside a stereotaxic frame. Their scalp was opened by an incision and after drilling a small hole 
into the skull 70 nl of 20 mM kainic acid (SIGMA) were injected over the course of one minute with a 
0.5 µl Hamilton syringe at the coordinates -1.9 mm (anterioposterior) -1.5 mm (mediolateral) using the 
bregma as a reference and -1.2 mm (dorsoventral) using the brain surface as a reference. The needle 
was left in place for 2 min and then slowly retracted over the course of another minute.  
Two days post-surgery anaesthetized mice were killed by transcardial perfusion with 20 ml of cold 
PBS followed by 20 ml of 4 % formaldehyde in PBS pH 7.4. Brains were dissected and post-fixed 
overnight, dehydrated and embedded in paraffin. Coronal cross sections at the level of the injection 
site were H&E-stained and the number of surviving and apoptotic neurons determined along the cornu 
ammonis. 
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Summary 
Due to their high energy demand, their highly polarized nature and the sheer length of their processes, 
neurons - more than any other cell type - depend on a well-balanced dynamic mitochondrial network. 
Drp1, the only known mammalian mediator of mitochondrial fission, is essential for neuronal 
development. Apart from studies in Purkinje cells, not much is known about the role of Drp1 in the 
postnatal brain. Tamoxifen-inducible Drp1 ablation in the forebrain leads to a swollen, perinuclearly 
aggregated mitochondrial phenotype and mitochondrial depletion from synapses resulting in impaired 
synaptic transmission. In contrast to Drp1-ablated neuronal cultures however, dendritic morphology 
and synapse numbers are not affected. Forebrain-specific Drp1-ablated mice also develop a complex 
metabolic phenotype characterized by weight loss, increased lipolysis and elevated corticosterone 
levels. Investigating this catabolic shift we found evidence for the activation of the unfolded protein 
response pathway (UPR) and altered ER morphology in Drp1-ablated brain regions, culminating in the 
induction of the multifaceted metabolic cytokine Fgf21. Fgf21 is normally produced in liver, fat and 
skeletal muscle in response to metabolic stress as fasting or exercise. It increases insulin sensitivity, 
regulates lipolysis in adipocytes and stimulates corticosterone production via receptors in the 
hypothalamus, thus explaining essential aspects of the observed catabolic phenotype. In summary, 
our results show that brain tissue can signal metabolic stress via Fgf21 induction, which induces a 
systemic metabolic shift. 
 Highlights 
 Loss of Drp1 in postmitotic hippocampal neurons causes impaired synaptic transmission in 
vivo while dendritic morphology and synapse numbers are retained. 
 Genetic Drp1 ablation impinges on endoplasmic reticulum morphology and causes ER stress 
 In Drp1-ablated brain tissue, activation of the unfolded protein response pathway locally 
induces the Fgf21 cytokine which, upon secretion, mediates a catabolic shift of systemic 
metabolism. 
Introduction 
Neurons have a particularly high energy demand and are heavily dependent on a functional 
mitochondrial network. Mitochondria constantly engage in membrane fusion and fission cycles, in 
which single organelles frequently bud off or merge with the mitochondrial syncytium. Single 
mitochondria sprouting from the network are transported along the cytoskeleton into dendrites, 
synapses and spines where they can contribute to local energy demands (Sheng, 2014). 
Mitochondrial fission is believed to be substantial for the sequestration of defective organelles and 
their removal from the network (McLelland et al., 2014; Twig et al., 2008), whereas. fusion is important 
for maintaining qualitative homogeneity of the syncytium through complementation (Chen et al., 2005). 
Mitochondrial fusion and fission are mediated by highly conserved dynamin-like proteins capable of 
self-assemble, GTP hydrolysis and of membrane remodeling (Bliek et al., 2013). Mitofusin 1 (Mfn1) 
and mitofusin 2 (Mfn2) are integral membrane proteins that are able to tether mitochondrial 
membranes by homo- or heterodimer formation thereby initiating mitochondrial fusion (Koshiba et al., 
2004). Mfn1 is primarily expressed on the outer mitochondrial membrane (OMM) while Mfn2 is also 
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expressed on the endoplasmic reticulum (ER) establishing trans-organelle connections (de Brito and 
Scorrano, 2008). Optic atrophy 1 (Opa1) is a protein of the inner mitochondrial membrane (IMM) 
where it executes its pro-fusion activity. Mutations in Mfn2 and Opa1 are causally linked to 
neurodegenerative diseases highlighting the importance of a well-maintained mitochondrial network 
for neuronal health. Mfn2 is linked to an axonal peripheral neuropathy known as Charcot-Marie-Tooth 
disease type 2A whereas Opa1 mutations cause autosomal-dominant optic atrophy (Alexander et al., 
2000; Delettre et al., 2000; Zuchner et al., 2004). The only known bona fide mammalian pro-fission 
protein of the dynamin superfamily is the cytosolic dynamin-related protein 1 (Drp1). It is activated by 
the phosphorylation of one or more residues and translocates to predefined mitochondrial fission sites 
where it binds to OMM-bound mitochondrial fission factor (Mff) (Otera et al., 2010). The exact 
molecular configuration of these fission sites is currently not fully understood. According to a currently 
favored model, Drp1 translocation is preceded by ER tubules wrapping around mitochondria to 
constrict the organelles (Friedman et al., 2011). A growing body of evidence suggests that this initial 
step of mitochondrial fission is driven by the constriction of actin and myosin filaments (DuBoff et al., 
2012; Korobova et al., 2013, 2014; De Vos et al., 2005) to create a geometric hotspot for the assembly 
of multimeric Drp1 complexes which – upon GTP hydrolysis - constrict further to complete the 
mitochondrial fission process (Bui and Shaw, 2013). The involvement of an unidentified inner-
mitochondrial fission machinery (similar to the FtsZ ring in chloroplastic and bacterial division) is 
currently being discussed (Friedman and Nunnari, 2014). Mutations of the drp1 gene can occur 
sporadically in humans as exemplified by a lethal syndromic birth defect of an infant with a dominant 
negative mutation in drp1 which displayed severe defects in brain development involving optic nerve 
atrophy and lactacidosis (Waterham et al., 2007). In mice, genetic knockout of Drp1 pan-neurally or in 
midbrain and cerebellum also leads to neurodevelopmental defects and death at P0 (Ishihara et al., 
2009; Wakabayashi et al., 2009). These neurodevelopmental deficiencies, possibly caused by 
inefficient transport of mitochondria to developing synapses and axonal growth cones (Morris and 
Hollenbeck, 1993; Verstreken et al., 2005), are in contrast to the neuroprotective effects of Drp1 
ablation in primary neuronal cultures, and in animals treated with the pharmacological Drp1 inhibitor 
mdivi-1 (reviewed by Oettinghaus et al., 2012). 
In this study we ablated Drp1 in postmitotic neurons of the adult mouse brain to bypass the critical role 
of Drp1 during brain development. Surprisingly, genetic Drp1 ablation from the forebrain of adult mice, 
resulted in a lethal metabolic phenotype. Here we show that a defect in mitochondrial fission in 
forebrain neurons impinges on the integrity of neuronal endoplasmic reticulum (ER) morphology, 
causing ER stress and activation of the unfolded protein response (UPR) pathway. As a direct result 
cortex and hippocampus, both of which not formally known to exert direct neuroendocrine functions, 
induce fibroblast growth factor 21 (Fgf21) - a stress-induced, catabolic cytokine that increases insulin 
sensitivity, regulates lipolysis in adipocytes and induces corticosterone production (Bookout et al., 
2013; Kharitonenkov et al., 2005; Luo and McKeehan, 2013). These observations demonstrate that 
brain tissue can signal ER stress via UPR-induced Fgf21, inducing a profound metabolic shift at the 
systemic level. 
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Results 
Inducible genetic ablation of Drp1 in the forebrain of adult mice 
Mice with loxP sites inserted in the Drp1 gene (Drp1
flx/flx
) (Ishihara et al., 2009) were crossed with mice 
expressing a Cre recombinase fusion protein that induces recombination only after tamoxifen binding 
(Cre
+
) (Erdmann et al., 2007). In these mice, Cre transgene expression is under the control of the 
CamKIIα promotor limiting recombination primarily to cortex and hippocampus. At 8 weeks of age the 
offspring of these crossings were injected i.p. with tamoxifen, yielding maximum depletion of Drp1 
protein in the forebrain as early as 10 days after tamoxifen administration (Figure1A). 
Drp1-ablated mice develop a lethal metabolic phenotype 
Unexpectedly, starting already at week 4 after tamoxifen administration, Drp1
flx/flx 
Cre
+
 mice 
progressively lost body weight compared to littermate controls (Figure 1B). In addition, the animals 
appeared weak and their coordination and physical condition decreased as measured by the rotarod 
performance test (Figure 1C). At an average of approximately 11 weeks after Drp1 ablation their body 
temperature dropped to as low as 25°C and mice died (Figures 1D and 1E). When checked for cold 
resistance at 6 weeks after Drp1 ablation, i.e. at a time point when body temperature was normal, we 
found that Drp1
flx/flx 
Cre
+ 
mice exposed for 4 hours to a 4°C environment showed a significantly 
reduced body temperature compared to control mice (Drp1
flx/flx
: 31.4 ± 0.4°C (n=6) versus Drp1
flx/flx 
Cre
+
: 28.0 ± 0.9°C (n=8)) (Figure 1F). Thus, it appears that Drp1-ablated mice are impaired in 
regulating their body temperature already several weeks before the phenotype enters its terminal 
stage. In order to investigate whether this phenotype was associated with a neurological component 
we used an 8-radial arm maze to assess hippocampus-dependent working memory function by a 
spontaneous alternation task. Four weeks after tamoxifen treatment, Drp1
flx/flx 
Cre
+ 
and Drp1
flx/flx
 
littermates were subjected to the task. When the percentage of correct alternations and total number 
of arm visits were scored, we noticed that Drp1
flx/flx 
Cre
+ 
mice are significantly impaired in their short-
term working memory (Drp1
flx/flx
: 72.9 ± 2.3 % (n=7) versus Drp1
flx/flx
 Cre
+ 
:60.0 ± 3.6 % (n=10)) (Figure 
1G). To verify that their compromised performance in the maze test was not due to impaired sensory 
perception, we confirmed that Drp1
flx/flx 
Cre
+ 
mice have normal visual acuity and olfaction (Figures S1A 
and S1B). Collectively, from these experiments we conclude that forebrain-specific Drp1 ablation 
causes a profound, ultimately lethal metabolic phenotype, which is accompanied by deficits in 
hippocampus-dependent memory functions.  
Mitochondria of Drp1-ablated neurons are greatly enlarged and show profound ultrastructural 
abnormalities 
As an initial step to characterize this metabolic phenotype we visualized mitochondrial morphology in 
hippocampal neurons of Drp1-ablated mice by immunohistochemistry. At around day 10 after Drp1 
ablation, we observed that enlarged spherical mitochondrial units started to aggregate in the neuronal 
perikarya (Figures 2A, S2A and S2B). Transmission electron microscopy (TEM) analysis (Figure 2B) 
revealed statistically significant differences in mitochondrial size as measured by the smallest radial 
diameter (Drp1
flx/flx
: 472 ± 49 nm versus Drp1
flx/flx 
Cre
+
: 1180 ± 108 nm) (Figure 2C) and that the lumen 
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of roughly 40% of all Drp1-ablated mitochondria was at least partly devoid of cristae (Drp1
flx/flx
: 9.1 ± 
5.5% versus Drp1
flx/flx 
Cre
+
: 39.7 ± 8.6%) (Figure 2D). This set of experiments demonstrates that 
blocking mitochondrial fission through forebrain-specific Drp1 ablation severely impairs mitochondrial 
morphology and ultrastructure in hippocampal neurons. 
Mitochondria of Drp1-ablated neurons have lower oxygen consumption rates but do not show 
increased oxidative stress 
To check whether this abnormal mitochondrial phenotype was associated with functional defects of the 
organelle, we measured oxidative phosphorylation on isolated mitochondria of hippocampus (Figure 
2E) and cortex (Figure S2C). In each case, we observed a significant decrease in mitochondrial ATP 
content in Drp1-ablated mice (Figure 2F and S2D), whereas no differences were noted in the 
mitochondrial membrane potential (Figure S2E, S2F and S2G). As Drp1 ablation in Purkinje neurons 
was recently reported to lead to increased oxidative stress (Kageyama et al., 2012), we measured the 
activity of reactive oxygen species (ROS) in Drp1-ablated brain tissue homogenates with fluorogenic 
detection probes but did not detect any significant changes in ROS production (Figure 2G and S2H). 
We also did not detect changes in the ratio of oxidized to reduced glutathione, nor significant 
differences in protein carbonylation or lipid peroxidation assays (Figure 2H-J and S2I-S2J). These 
results indicate that the changes in mitochondrial morphology and ultrastructure that occur at week 4 
after Drp1 ablation are accompanied by significantly reduced respiratory capacity and ATP content of 
hippocampal mitochondria of Drp1
flx/flx 
Cre
+
 mice. 
Drp1 ablation causes a dilation of rough ER cisternae and activates the UPR pathway 
Analyzing TEM images of the hippocampus we noticed that in Drp1
flx/flx 
Cre
+ 
animals the normally 
tubular architecture of the rough endoplasmic reticulum (rER) had changed into dramatically dilated 
and circular structures (Figure 3A and 3B). Hypothesizing that this change in ER morphology might 
represent a reflection of ER stress, we checked various parameters of the unfolded protein response. 
Indeed, analyzing forebrain protein lysates of 4-week-Drp1-ablated mice, we detected increased eIF2α 
phosphorylation in Drp1
flx/flx 
Cre
+
 mice compared to Drp1
flx/flx
 controls (Figures 3C, 3D and S3A-S3D). 
In addition, already at 4 weeks after Drp1 ablation, we observed an increase in Chop mRNA levels 
(Figure 3G). With phenotype progression, we also find increased Bip/Grp78 as well as ATF4 levels at 
week 10 after Drp1 ablation (Figures 3C, 3E, 3F and S3A-S3C). In contrast, at no time point 
throughout phenotype progression did we find any evidence for the activation of the IRE1-intiated UPR 
subpathway, in particular no altered Xbp1 splicing (data not shown). Nevertheless, increased eIF2α 
phosphorylation, elevated protein levels of Bip/Grp78 and ATF4 as well as increased Chop mRNA 
levels in forebrain tissue of Drp1
flx/flx 
Cre
+
 mice collectively indicate that a block in mitochondrial fission 
is associated with profound morphological alterations of the rER activating an essential pathway of the 
unfolded protein response. 
Drp1-ablated pyramidal CA1 neurons have a defect in synaptic transmission 
To test how the severe mitochondrial deficiency in concert with altered ER morphology and UPR 
activation under conditions of Drp1 ablation affect neuronal health, we performed whole-cell patch-
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clamp recordings of individual CA1 pyramidal neurons in acute hippocampal slices from animals at 4 
weeks after tamoxifen treatment. Pyramidal CA1 neurons of Drp1
flx/flx
 Cre
+
 mice had normal basic 
electrophysiological properties and resting membrane potential (Drp1
flx/flx
: -65.7 ± 1.4 mV (n=10) 
versus Drp1
flx/flx
 Cre
+
: -65.2 ± 2.4 mV (n= 7)) (Figure 4A). To test for differences in cellular excitability, 
current steps of increasing amplitude were injected. All evaluated parameters including action potential 
(AP) peak amplitude and half-width were not different between Drp1
flx/flx
 Cre
+
 and control mice 
(Figures 4B and 4C) indicating that the somatic generation of AP output was not affected by Drp1 
ablation. Biocytin-filling of patch-clamped pyramidal cells did also not reveal any substantial changes 
in dendritic morphology (data not shown). To clarify whether the transport to the synapses of the 
grossly enlarged mitochondria of Drp1
flx/flx
 Cre
+
 mice was impaired, randomly selected synapses in 
TEM images of hippocampal neurons were checked for the presence of presynaptic mitochondria. 
Indeed, the percentage of synapses containing presynaptic mitochondria was greatly reduced in the 
hippocampi of Drp1
flx/flx
 Cre
+
 mice (Drp1
flx/flx
: 35.7 ± 7.6 % (n=4) versus Drp1
flx/flx 
Cre
+
: 11 ± 4.1% (n=4)) 
(Figure 4D). Therefore, we decided to test whether this mitochondrial depletion from synaptic terminals 
would significantly hamper synaptic transmission using field potential recordings. Stimulation of 
Schaffer collateral inputs evoked field excitatory postsynaptic potentials (fEPSP) with normal pair-
pulse facilitation (Δt= 10 and 100 ms), indicating normal release probability (Figure 4E). When 
synaptic transmission was challenged by application of 100 stimuli of either 10 or 100 Hz, under both 
conditions fEPSP facilitation was significantly reduced in brain slices from Drp1
flx/flx
 Cre
+
 mice (Figures 
4F, 4G, S4A and S4B). This result is consistent with previous studies in Drosophila indicating that 
synaptic mitochondria are critical for reserve pool vesicle mobilization (Verstreken et al., 2005). 
Furthermore, this defect in synaptic transmission appears sufficiently pronounced to explain the 
memory impairment observed in the Drp1
flx/flx
 Cre
+
 mice. 
Drp1-ablated mice develop hippocampal atrophy 
Several previous studies indicate that Drp1 ablation in vitro causes a reduction in the number of 
dendrites, spines, and synapses (reviewed by Oettinghaus et al., 2012). Therefore, we performed 
Golgi silver impregnations on brain sections of Drp1-ablated mice. Upon Scholl analysis we verified 
that, while overall dendritic tree morphometry was unchanged, dendrites were significantly shorter in 
Drp1
flx/flx 
Cre
+
 mice at 10 weeks after Drp1 ablation (Figures 4H and 4I), which was associated with 
significantly decreased hippocampal volumes (Drp1
flx/flx
: 2.65 ± 0.08 mm
3
 (n=6) versus Drp1
flx/flx 
Cre
+
: 
1.95 ± 0.33 mm
3 
(n=5)) (Figure 4L). In contrast, cortical and midbrain volumes did not change (Figure 
4M). To test whether this hippocampal atrophy was associated with a loss of spines, we quantified 
spine numbers on apical dendritic trees of pyramidal CA1 neurons, but did not find a difference (Figure 
4J). Likewise, no reduction in synapse numbers, as assessed by co-localization of fluorescent stains 
for pre- (VGLUT2) and postsynaptic (PSD95) markers in laser confocal image zeta stacks, was 
found.(Figure 4K). Despite relatively subtle morphological changes influencing neuronal and especially 
hippocampal function, our analyses indicate that, in vivo, Drp1-ablated hippocampal CA1 neurons may 
be more resistant to mitochondrial and ER stress than neurons under in vitro conditions,  
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Metabolism of Drp1-ablated mice shifts towards lipolysis, associated, with significantly elevated 
corticosterone levels 
As it is not immediately apparent how the neuronal phenotype with hippocampal atrophy and memory 
deficits, induced through a forebrain-specific defect in mitochondrial fission could be linked to weight 
loss and decreased body temperature, a number of metabolic tests was performed. Upon housing 
mice at four weeks after Drp1 ablation in metabolic cages, their respiratory exchange ratios were 
found to be significantly reduced (Drp1
flx/flx
: 0.988 ± 0.011 (n=8) versus Drp1
flx/flx 
Cre
+
: 0.934 ± 0.012
 
(n=8)) (Figures 5A and 5F), indicative of a greater contribution of lipid β-oxidation towards ATP 
production in Drp1
flx/flx 
Cre
+
 animals. No changes in ambulatory activity, overall metabolic rates, and 
food or water intake were observed (Figures S5A-S5E). Corresponding to the results of respiratory 
exchange ratio measurements we also verified by EchoMRI a decrease in the percentage of body fat 
in Drp1-ablated mice (Drp1
flx/flx
: 9.7 ± 0.01% (n=7) versus Drp1
flx/flx 
Cre
+
: 7.75 ± 0.62% (n=7)) (Figure 
5B). In addition, histological analysis of white (WAT) and brown adipose tissue (BAT) revealed smaller 
WAT adipocytes and smaller fat vacuoles in BAT in Drp1-ablated mice (Figures 5C, D). Finally, at 
around 10 weeks after Drp1 ablation, levels of the thyroid hormone T4, involved in body temperature 
regulation, were found to drop,significantly (Drp1
flx/flx
: 3.85 ± 0.25 µg/dl (n=9) versus Drp1
flx/flx 
Cre
+
: 
2.74 ± 0.31 µg/dl (n=8)) (Figure 5E). Next, we tested whether hormonal dysregulation of appetite could 
have caused or contributed to the progressive body weight loss of Drp1-ablated mice. Plasma levels of 
leptin, an appetite-suppressing hormone secreted by adipocytes, were unchanged (Drp1
flx/flx
: 418.7 ± 
99.3 pg/ml (n=13) versus Drp1
flx/flx 
Cre
+
: 353.4 ± 103.6 pg/ml (n=16)) (Figure S5F). In contrast, plasma 
levels of active ghrelin, which signals appetite, were increased in Drp1
flx/flx 
Cre
+
 animals (Drp1
flx/flx
: 
336.3 ± 39 pg/ml (n=8) versus Drp1
flx/flx 
Cre
+
: 575.6 ± 152.5 pg/ml (n=4)) (Figure S5G), although these 
measurements did not reach statistical significance. Having established that a major hormonal 
suppressors (leptin) or stimulators of appetite (ghrelin) are unlikely to account for the observed weight 
loss in Drp1-ablated mice, long-term monitoring of food intake was performed. We found that Drp1-
ablated mice periodically eat even more than their wildtype controls with their food intake declining 
only during the terminal stages of the phenotype (Figure 5E). We also subjected mice to glucose- and 
insulin-tolerance tests in order to exclude any difficulties in clearing glucose from blood. At 10 weeks 
after Drp1 ablation a general decrease in blood glucose was found, but glucose clearance in response 
to either high glucose levels or to insulin were unaffected (Figures S5H and S5I). Finally, to solve the 
so far explained discrepancy between weight loss and increased food intake in Drp1-ablated mice, we 
measured corticosterone (the major glucocorticoid in rodents) which drives gluconeogenesis, protein 
degradation, and lipolysis. Already at 6 weeks after Drp1 ablation corticosterone serum levels of Drp1-
ablated mice were found to be significantly increased (Drp1
flx/flx
: 111.5 ± 18.5 ng/ml (n=8) versus 
Drp1
flx/flx 
Cre
+
: 284.6 ± 33.7 ng/ml (n=4)) (Figure 5G), providing a first clue to the mechanisms 
underlying the profound shift in metabolism observed in forebrain-specific-Drp1-ablated mice.  
Locally induced in Drp1-ablated brains via the UPR-pathway, the cytokine Fgf21 accumulates in the 
serum 
Corticosterone levels are controlled by the hypothalamic-pituitary-adrenal axis, which can be 
stimulated by the catabolic cytokine Fgf21 (Bookout et al., 2013). By ELISA Fgf21 plasma levels were 
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found to be increased in Drp1
flx/flx 
Cre
+
 mice (Figure 5H). We also checked Fgf21 mRNA expression 
levels in the brain and other relevant tissues and found increased mRNA levels specifically in regions 
of Drp1 ablation (cortex, hippocampus), whereas no Fgf21 mRNA increases were observed in tissues 
where the cytokine is normally produced in response to metabolic stress (liver, skeletal muscle, WAT; 
Luo and McKeehan, 2013) (Figure 5I). With regard to our observation that Drp1 ablation in the brain 
activates the eIF2α/ATF4 signaling axis of the UPR, it is interesting to note that Fgf21 expression was 
previously shown to be induced by ATF4 in vitro (Muñoz et al., 2013). Therefore we checked whether 
Fgf21 activators other than ATF4 such as PPARα (Badman et al., 2007; Inagaki et al., 2007), PGC1α 
(Estall et al., 2009) and phospho-Akt (Tyynismaa et al., 2010) were also involved. By screening 
transcriptional levels of PPARα, PPARβ, PGC1α, PGC1β we did not find any increases in either of 
these mRNAs (Figure S5J); likewise, Western Blotting for phosphorylated Akt1 did not reveal any 
differences between Drp1
flx/flx 
Cre
+ 
and control mice (Figures S5K, L). From these observations and 
taking into account our results represented by Figure 3 (including Figure S3), we conclude that Fgf21 
induction in Drp1
flx/flx 
Cre
+ 
mice
 
most likely occurs through activation of the eIF2α/ATF4 signaling axis 
of the UPR. 
Experimental procedures 
Mice 
Drp1
flx/flx
 mice have been described previously (Ishihara et al., 2009). The CamKIIα CreERT2 (Cre
+
) 
mouse was purchased from the European Mouse Mutant Archive (EMMA strain 02125) (Erdmann et 
al., 2007). At 8 weeks of age Drp1
flx/flx 
Cre
+
 mice were injected i.p. with 1 mg tamoxifen (10 mg/ml 
tamoxifen (Sigma) dissolved in a 9:1 ratio of sunflower seed oil to ethanol) twice per day on five 
consecutive days to induce recombination of the Drp1 locus. 
Histology 
Serial, coronal cross sections of formalin-fixed, paraffin-embedded (FFPE) mouse brains were 
prepared and sections representing the coordinates bregma (-1.34 mm) – (-2.46 mm) were selected 
and stained for COX subunit1a (Abcam). Z-stacks were recorded with an inverted Zeiss Axiovert 200M 
LSM 510 Meta confocal microscope with a 100x/1.4 Oil DIC objective using Enterprise 405 nm and 
Argon 488 nm lasers. Z-stacks were projected onto a single plane using ImageJ. Synapse numbers 
were quantified as described previously (Ippolito and Eroglu, 2010). Golgi staining was performed on 
PBS-perfused, unfixed brains using a commercial kit (FD Neurotechnologies). 
Hippocampal volume was calculated from H&E stained 100-μm-spaced, serial, coronal cross sections 
applying the Cavalieri principle. For cortical and midbrain volume, only sections representing 
coordinates bregma 1.1 mm – (-1.2 mm) were considered, using the corpus callosum as reference. 
Transmission electron microscopy 
Semithin sections of osmium-stained hippocampi were prepared in order to identify hippocampal 
neurons, of which ultrathin sections were prepared. Imaging was done on a Phillips CM100 
transmission electron microscope, and morphological analysis of ER and mitochondria was performed 
using ImageJ. The minimal radial diameter of a mitochondrion was calculated using a rotating calipers 
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algorithm and the roundness of rER structures was calculated using standard shape descriptors of 
ImageJ. 
Electrophysiology 
Transverse 350 to 400-m-thick hippocampal brain slices were cut in a sucrose-based solution. 
During electrophysiological recordings, slices were continuously superfused with artificial 
cerebrospinal fluid (ACSF) maintained at 32-33ºC. During whole-cell patch-clamp recordings, 
hippocampal CA1 pyramidal neurons were filled with biocytin for subsequent morphological 
evaluation. Field excitatory postsynaptic potentials (fEPSP) were recorded with glass pipettes filled 
with 1 M NaCl placed in the stratum radiatum of the CA1 region. The stimulating electrode was placed 
~500 µm away to stimulate Schaffer collaterals. Data analysis was performed offline using customized 
scripts written in python and Stimfit.  
Isolated mitochondria 
Mitochondria were isolated from cortex and hippocampus as previously described (Rhein et al., 2009). 
Oxygen consumption rate was measured in isolated mitochondria from cortex and hippocampus using 
a Seahorse Bioscience XF24Analyzer. ATP content from isolated mitochondria was determined using 
a bioluminescence assay (ViaLighTM HT; Cambrex Bio Science). 
Behavior 
Visual Performance was tested in the Morris Walter tank with a visible platform. Olfaction was checked 
using the cookie finding test. To score hippocampus-dependent working memory, the spontaneous 
alternation task was employed based on the spontaneous alternation paradigm (Ragozzino et al., 
1996). 
Metabolic measurements 
Metabolic parameters (respiratory exchange ratio, motor activity, food and water intake) were 
measured using CLAMS equipment (Columbus Instruments). Mouse body composition was monitored 
with an EcoMRI-100 qNMR (EchoMRI Medical Systems). 
Real-time PCR 
RNA was isolated using commercial kits (Qiagen). Reverse-transcriptase PCR was performed using 
the High Capacity cDNA Reverse Transcription Kit (Invitrogen). Real-time PCR was performed using 
TaqMan assays (Life Technologies) on a 7900HT Real-Time PCR System (Applied Biosystems). 
Experimental details on these assays are specified in Supplemental Data. 
Western Blot 
Proteins of brain lysates were separated on 4-12% BisTris SDS-PAGE gels, blotted onto nitrocellulose 
membranes using the iBlot Dry Blotting System (Life Technologies), and probed with the indicated 
primary antibodies and isotype-matched secondary antibodies conjugated to horseradish peroxidase. 
Please refer to Supplemental Data for a complete list of the antibodies used. Signals were detected 
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using ECL (GE Healthcare). For the detection of carbonylated protein manufacturer`s instructions for 
the OxyBlot Protein Oxidation Detection Kit (Millipore) were followed.  
ELISAs and colorimetric assays 
Hormone levels were determined by ELISA on either serum or plasma and thiobarbituric acid reactive 
substances (TBARS) and glutathione levels were determined by colorimetric assays on brain 
homogenates. Blood was collected between 9 and 10 am by either tail vein or heart puncture. A 
complete list of all assays used is given in the Supplemental Data section. 
Discussion 
Dysregulated mitochondrial morphology has been implicated in a number of neurodegenerative 
diseases. In mouse models, the genetic knockout of essential mediators of mitochondrial fusion and 
fission results in early embryonic lethality, reflecting the physiological importance of properly regulated 
mitochondrial dynamics. While the constitutive knockout of the fission-mediating protein Drp1 is 
embryonically lethal between E17.5-18.5, brain-specific Drp1 ablation using a nestin promoter-driven 
knockout strategy is lethal around birth (Ishihara et al., 2009; Wakabayashi et al., 2009). In order to 
by-pass the neurodevelopmental defects due to Drp1 ablation, we employed a murine model that 
allowed us to ablate Drp1 in vivo in adult, postmitotic neurons of the forebrain. To this end, we crossed 
Drp
flx/flx
 mice (Ishihara et al., 2009) with mice that express Cre recombinase under the control of a 
tamoxifen-inducible CamKIIα promoter. 
Here we show that inducible Drp1 ablation in the adult mouse forebrain leads to mitochondrial 
aggregation in neuronal perikarya, accompanied by altered cristae morphology and lower oxygen 
consumption rates. While this does not immediately increase ROS formation, we do see an induction 
of various ER stress parameters. In particular, we find that the PERK-mediated UPR pathway is 
activated, and this is paralleled by a profoundly altered ER morphology.  
In a model of angiotensin-II-induced chronic hypertension neuronal ER stress is associated with 
similar ER morphology changes reflecting that neuronal ER stress and ER shape are interconnected 
(Young et al., 2012). However, particularly in neurons, ER fragmentation seems to be a reversible 
phenomenon in response to insults not necessarily connected to ER stress (Kucharz et al., 2013), and 
thus it is possible that ER fragmentation per se is part of an general adaptive stress response. The 
origin of the stress in our Drp1 ablation model could also be due to mitochondrial stress caused by 
respiratory deficiency and associated changes in mitochondrial morphology. Alternatively, as we 
detect eIF2α phosphorylation prior to Bip upregulation, eIF2α could also be phosphorylated by the 
kinase GCN2, which gets activated during amino acid deprivation (Donnelly et al., 2013). 
ER and mitochondrial network are tightly interconnected by membrane structures called mitochondria 
associated ER membranes (MAMs). Disruption of MAMs by mutant α-synuclein disrupts ER-
mitochondria interorganellar connections, and induces Drp1-independent fragmentation of 
mitochondria (Guardia-Laguarta et al., 2014). Likewise, MAMs disruption by deletion of Mfn2, which 
interconnects ER and mitochondria, induces fragmentation of both organelles (de Brito and Scorrano, 
2008). Hence, it seems very likely that profound morphological changes of one organelle inevitably 
impinge on the morphological integrity of the other. Mfn2-deficient cells also show UPR activation 
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(Muñoz et al., 2013), indicating that disruption of trans-organelle connections is sufficient to induce ER 
stress. It was previously shown that Drp1 also localizes to the ER where it can mediate ER 
morphological changes (Pitts et al., 1999; Wikstrom et al., 2013), indicating that Drp1 may directly 
regulate ER shape. 
Neurons that have an aggregated mitochondrial phenotype show a reduction in dendritic and synaptic 
structures in vitro (reviewed in Oettinghaus et al., 2012). However, as discussed before, we could not 
show that in our in vivo model. Even though they have to cope with a decrease in oxidative 
phosphorylation and ER stress, Drp1 ablated pyramidal CA1 neurons have a regular dendritic tree 
morphology as well as regular synapse and spine numbers; in addition, no neurodegeneration is 
observed within 10 weeks of Drp1 ablation. In contrast, Drp1 ablated Purkinje neurons undergo 
neurodegeneration within 5 weeks after Drp1 ablation (Kageyama et al., 2012). As pointed out earlier, 
Drp1 is of particular importance for dendrite and synapse formation during neuronal development. In 
this context it is interesting to note that murine Purkinje neuron differentiation continues during the first 
three weeks after birth (Chizhikov and Millen, 2003), and that Drp1 ablation in the Purkinje cell model 
of Kageyama and co-workers (Kageyama et al., 2012) occurs at three weeks after birth. Therefore, 
one cannot exclude that Drp1 ablation overlaps with the final stages of Purkinje neuron differentiation, 
which might render them more susceptible to degeneration. In our model we can exclude 
neurodevelopmental defects caused by Drp1 ablation (tamoxifen knockout induction occurs at the age 
of 8 weeks), and our results show that dendritic and synaptic structures are largely unaffected by Drp1 
ablation. We also find that basic functions are maintained in Drp1 ablated neurons: they generate APs, 
maintain their plasma membrane potential and are capable of synaptic transmission. However, 
numbers of presynaptic mitochondria are decreased and, when challenged by high frequency 
stimulation, synaptic transmission of Drp1 ablated neurons is impaired, indicating compromised 
neuronal function under certain conditions.  
Interestingly, a similar electrophysiological phenotype with a similar mitochondrial morphology has 
been observed at neuromuscular junctions of Drp1 mutant flies (Verstreken et al., 2005). While this 
phenotype has been attributed to ATP-dependent effects on reserve pool vesicle recycling due to the 
lack of mitochondria at the bouton, it has been shown more recently in murine hippocampal neurons, 
that Drp1 is also directly involved in reserve pool vesicle formation (Li et al., 2013). Therefore, the 
defect in synaptic transmission in our model could well be sufficient to explain the impaired short-term 
spatial working memory verified during behavioral testing of our Drp1 ablated mice.  
Finally, we observed a specific reduction in hippocampal volume which we believe is due to the nature 
of the metabolic phenotype characterized by increased circulating corticosterone. Hippocampal 
atrophy is a hallmark of post-traumatic stress disorder in which pathological stress hormone levels 
inhibit hippocampal neurogenesis (Bremner, 2006). We find that Drp1 ablation in the forebrain leads to 
a metabolic shift characterized by increased corticosterone levels. Corticosterone is the main 
glucocorticoid in rodents and has a variety of metabolic effects: it mobilizes energy stores by inducing 
lipolysis in fat tissue and by protein degradation in muscle, and it activates gluconeogenesis in the 
liver. Predominant in our mice was the effect on fatty acid metabolism. Despite normal feeding 
behavior, Drp1 ablated mice lost weight and had a decreased percentage of body fat. Corticosterone 
levels can be regulated via Fgf21 receptor binding in the hypothalamus (Bookout et al., 2013) and 
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accordingly, we find elevated Fgf21 plasma levels in forebrain-Drp1 ablated mice. We also find that 
Fgf21 mRNA expression is only increased in Drp1-ablated brain regions. Compellingly, forebrain-Drp1 
ablated mice share a similar metabolic phenotype with Fgf21 overexpressing mice regarding weight 
development, lower glucose levels, fat tissue histology and corticosterone levels (Bookout et al., 2013; 
Kharitonenkov et al., 2005; Zhang et al., 2012). In contrast, however, mice overexpressing Fgf21 have 
extended life spans, similar to mice fed a calorie-restricted diet (Zhang et al., 2012). While we do not 
have a definitive explanation for this phenotypic discrepancy, the difference between those two 
models could potentially be attributed to functionally impaired Drp1 ablated neurons, and to a 
difference in the physiological distribution of Fgf21. 
In our model the CamKIIα promoter that controls the CreERT2 transgene is also active in the 
paraventricular nucleus in the hypothalamus (Erdmann et al., 2007). It recently became apparent, that 
mitochondrial dynamics can also be involved in intraneuronal signal transduction. Changes of 
neuronal mitochondrial network morphology can be a specific reaction to hormone or metabolite 
sensing in certain highly-specialized hypothalamic neuronal subpopulations (Carneiro et al., 2012; 
Dietrich et al., 2013; Schneeberger et al., 2013). At this point, we cannot exclude that Drp1 ablation 
affects hormone or metabolite sensing in this subset of neurons, and that this also contributes to the 
observed metabolic phenotype. β-klotho – a substantial component of the Fgf21 receptor – 
expression, however, is limited to the suprachiasmatic nucleus where the Cre-regulating promoter in 
our model is not active (Bookout et al., 2013).  
Fgf21 in our model is produced in close proximity to its hypothalamic receptor and induces 
corticosterone production as efficiently as systemic Fgf21 overexpression in mice which have a much 
higher Fgf21 levels. The physiological role of Fgf21 is perceived as a metabolic stress hormone 
mediating communication between stressed organ and adipose tissue, thereby inducing a beneficial 
metabolic shift (Luo and McKeehan, 2013). It is thus very likely, that Fgf21 production in Drp1 ablated 
brain is in fact beneficial to the organism and initiates a metabolic shift that supports Drp1 deficient 
brain regions and maintains their functionality. 
Fgf21 has recently also been identified as biomarker for mitochondrial myopathies (Suomalainen et 
al., 2011). It therefore seems an attractive hypothesis that Fgf21 signaling may play a role in 
neurodegenerative diseases where defects in mitochondrial morphology and function as well as ER 
stress are known to occur. In fact, altered mitochondrial morphology (Wang et al., 2009) and increased 
levels of phosphorylated eIF2α (Chang et al., 2002) in AD brains have been reported.  
In summary, we conclude that Drp1 function is pivotal in postmitotic neurons which display a 
remarkable resilience and are able to adapt to blocked mitochondrial fission caused by Drp1 ablation. 
Most surprisingly, these intraneuronal adaptations are communicated to the organism via the catabolic 
cytokine Fgf21 which induces a profound metabolic shift (Figures 6A and 6B). The results presented in 
this work provide a new perspective on the interplay of mitochondria with the endoplasmic reticulum 
and will hopefully inspire a new direction of research in the scientific mitochondrial community. 
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Figure Legends 
Figure 1 Drp1-ablated mice display a lethal metabolic phenotype 
(A) 4 week-old Drp1
flx/flx 
and Drp1
flx/flx
 Cre
+
 mice were injected i.p. twice daily for 5 consecutive days 
with 1mg of tamoxifen, and sacrificed at the indicated time after the last injection. Hippocampal lysates 
were separated by SDS-PAGE and immunoblotted using the indicated antibodies. 
(B) Body weight of Drp1-ablated and control mice. Data represent average ±SEM of at least 4 animals. 
(C) Rotarod performance of Drp1-ablated and control mice. Data represent average ±SEM of at least 
8 animals. 
(D) Body temperature of Drp1-ablated animals plotted as a function of days to death. Data represent 
average ±SEM of at least 8 animals. 
(E) Kaplan Meier Plot of Drp1-ablated and control animals. Each group is represented by at least 15 
animals. 
(F) Drp1-ablated and control animals were exposed to a 4°C cold environment for the indicated time 
and body temperature was recorded. Data represent average ±SEM of at least 6 animals. 
(G) Drp1-ablated and control animals were placed in an 8-arm, radial maze which they had to 
systematically explore. Correct alternation of arm visits was scored. Data represent average ±SEM of 
at least 7 animals. 
The asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. See also Figure S1 
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Figure 2 Parameters of Drp1-ablated mitochondria 
(A) Coronal sections of FFPE brains of 4-week-Drp1-ablated and control mice were immunostained for 
cytochrome c oxidase subunit 1 (green) and with DAPI (blue). Images show CA1 pyramidal neurons. 
White scale bar represents 10 µm. 
(B) Representative TEM images of mitochondria of hippocampal neurons of 4-week-Drp1-ablated and 
control animals. “N” indicates the nucleus and “M” indicates mitochondria. Black scale bar represents 
1 µm. 
(C) Smallest radial diameter of 4-week-Drp1-ablated and control mitochondria measured on TEM 
images. Data represent average ±SEM of at least 4 animals of which the mitochondria of at least 80 
neurons were measured. 
(D) Percentage of mitochondria with abnormal cristae of 4-week-Drp1-ablated and control 
mitochondria measured on TEM images. At least one third of the mitochondrial lumen of the counted 
mitochondria was devoid of cristae. Data represent average ±SEM of at least 4 animals of which at 
least 100 mitochondria were scored. 
(E) Oxygen consumption rate of isolated, hippocampal mitochondria of 4-week-Drp1-ablated and 
control mice was measured with a Seahorse Bioscience XF24 Analyzer. Substances were injected at 
the indicated time points. Data represent average ±SEM of at least 4 animals whose hippocampi were 
pooled and the measurements were performed with at least 6 replicates. 
(F) ATP content of isolated, hippocampal mitochondria of 4-week-Drp1-ablated and control mice was 
measured with a bioluminescence assay. Data represent average ±SEM of at least 4 animals whose 
hippocampi were pooled and the measurements were performed with at least 8 replicates. 
(G) Oxidative stress levels represented by DHR and MitoSox fluorescence in hippocampal tissue 
homogenate of 4-week-Drp1-ablated and control mice. Data represent average ±SEM of at least 4 
animals whose hippocampi were pooled and the measurements were performed with at least 4 
replicates. 
(H+I) Ratio of oxidized to reduced glutathione and thiobarbituric acid reactive substance (TBARS) 
levels (representing lipid peroxidation) in hippocampal lysates of 4-week-Drp1-ablated and control 
mice were measured by commercial colorimetric kits. Data represent average ±SEM of at least 6 
animals. 
(J) Hippocampal lysates of 4-week-Drp1-ablated and control mice were separated by SDS-PAGE and 
immunoblotted using an antibody for carbonylated protein of a commercial oxyblot kit. Data represent 
average ±SEM of at least 4 animals. 
The asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. See also Figure S2 
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Figure 3 Drp1 ablation induces morphological ER alterations and ER stress 
(A) Representative TEM images of the rER of hippocampal neurons of 4-week-Drp1-ablated and 
control animals. Black scale bar represents 1 µm. 
(B) rER circularity (4π x Area/ Perimeter
2
, a value of 1 represents a full circle) of rER structures of 
Drp1-ablated and control hippocampal neurons as measured on TEM images. Data represent average 
±SEM of at least 4 animals of which rER structures of at least 80 neurons were measured. 
(C) Representative Western blot of Drp1-ablated and control hippocampal lysates which were 
separated by SDS-PAGE and immunoblotted using the indicated antibodies. 
(D) Quantification of phosphorylated elF2α band intensity normalized to total elF2α. Data represent 
average ±SEM of at least 4 animals. 
(E+F) Quantification of ATF4 and Bip band intensity normalized to actin. Data represent average 
±SEM of at least 4 animals. 
(G) RNA was isolated from different mouse brain regions at indicated time points after tamoxifen-
induced Drp1 ablation. RNA was retrotranscribed into cDNA and a qRT-PCR performed using the 
TaqMan system. Chop mRNA ct values were normalized against 18S rRNA ct values. Data represent 
average ±SEM of at least 4 animals.  
The asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. See also Figure S3 
Manuscript -44 
 
Figure 4 Drp1 ablation does not lead to neurodegeneration but leads to impaired synaptic 
transmission 
(A) Hippocampal slice cultures of 4-week-Drp1-ablated and control animals were prepared and 
pyramidal CA1 neurons were patch clamped and resting membrane potential was measured. Data 
represent average ±SEM of at least 7 neurons. 
(B+C) One-second-long current steps of increasing amplitude were injected to induce action potentials 
and maximal amplitude and half width were plotted. Data represent average ±SEM of at least 7 
neurons. 
(D) Synapses in TEM images of 4-week-Drp1-ablated and control hippocampi were screened for the 
presence of presynaptic mitochondria. Data represent average ±SEM of at least 4 animals of which at 
least 100 synapses were screened. 
(E) Representative field excitatory postsynaptic potentials (fEPSP) before and after 10s of 10Hz 
stimulation. fEPSPs were recorded in the CA1 stratum radiatum in 4-week-Drp1-ablated and control 
hippocampal slice cultures after stimulating the Schaffer collaterals. 
(F) Mean slope of fEPSPs during the time course of a 10s 10Hz stimulation. Data represent average 
±SEM of at least 6 neurons. 
(G) Maximal mean fEPSP slope after 10s 10Hz stimulation. Data represent average ±SEM of at least 
6 neurons. 
(H) Representative camera lucida drawing of Golgi stained 10-week-Drp1-ablated and control CA1 
pyramidal neurons. 
(I) Scholl – analysis of Golgi stained 10-week-Drp1-ablated and control CA1 pyramidal neurons. Each 
data point represents the number of intersections of the dendritic tree with concentric rings that were 
drawn with increasing diameter around the soma. Data represent average ±SEM of at least 100 
neurons. 
(J) Number of spines per µm on dendrites of the apical dendritic tree of CA1 pyramidal neurons. 
(K) Coronal cross sections of 10-week-Drp1-ablated and control brains were stained with the 
presynaptic marker VGLUT2 (green) and the postsynaptic marker PSD95 (red). A 150 μm x 150 μm x 
5 μm confocal image stack in the CA1 stratum radiatum was recorded and the number of overlapping 
punctae was determined. Data represent average ±SEM of at least 5 animals of which 4 stacks each 
were recorded. White scale bar represents 5 µm. 
(L+M) Hippocampal Volume was recorded on H&E-stained, serial, coronal cross sections of 8-week-
Drp1-ablated animals applying the Cavalieri principle. For cortical and midbrain volume only sections 
representing the coordinates bregma 1.1 mm – (-1.2 mm) were considered. Data represent average 
±SEM of at least 5 animals. 
The asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. See also Figure S4 
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Figure 5 Drp1 ablation in the forebrain induces metabolic shift transmitted by Fgf21 
(A) 4-week-Drp1-ablated and control animals were housed individually in metabolic cages and their 
respiratory gas exchange was monitored. Data represent average ±SEM of at least 8 animals. 
(B) Body fat composition of 4-week-Drp1-ablated and control animals was measured via EchoMRI. 
Data represent average ±SEM of at least 8 animals. 
(C+D) H&E staining of FFPE white and brown adipose tissue sections of mice was performed 10 
weeks after Drp1 ablation. White adipose tissue was blindedly classified by three operators by cell size 
and brown adipose tissue by vacuole size. Chi-square test for trend analysis revealed a significant 
difference in frequency distribution for white (P:0.0075) and brown adipose tissue (P:0.0249) when 
comparing Drp1-ablated and control mice  
(E) Food intake of Drp1-ablated and control animals was monitored. Data represent average ±SEM of 
at least 4 animals.  
(F+G) T4 and corticosterone serum levels in tail vein blood of Drp1-ablated and control animals were 
determined by ELISA. Data represent average ±SEM of at least 4 animals. 
(H) FGF21 plasma levels in cardiac blood of Drp1-ablated and control animals were determined by 
ELISA. Data represent average ±SEM of at least 3 animals. 
(I) RNA was isolated from different mouse brain regions at indicated time points after tamoxifen-
induced Drp1 ablation. RNA was retrotranscribed into cDNA and a qRT-PCR performed using the 
TaqMan system. FGF21 mRNA ct values were normalised against 18S rRNA ct values. Data 
represent average ±SEM of at least 4 animals.  
The asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. See also Figure S5 
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Figure 6 Graphic Abstract 
(A) Drp1 ablation in the brain leads to mitochondrial and ER stress and morphological changes in 
these organelles which leads to Fgf21 induction via unfolded protein response pathway signaling via 
receptor binding in the hypothalamus Fgf21 produced in the brain induces corticosterone in the 
suprarenal glands.  
(B) Chronically elevated Fgf21 and corticosterone levels induce various effects on peripheral 
metabolic organs, resulting in a systemic catabolic shift. 
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Figures 
Figure 1 Drp1-ablated mice display a lethal metabolic phenotype 
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Figure 2 Parameters of Drp1-ablated mitochondria 
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Figure 3 Drp1 ablation induces morphological ER alterations and ER stress 
 
 
Manuscript -50 
Figure 4 Drp1 ablation does not lead to neurodegeneration but leads to impaired synaptic 
transmission 
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Figure 5 Drp1 ablation in the forebrain induces metabolic shift transmitted by Fgf21 
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Supplemental Information 
Supplemental Experimental Procedures 
Mice 
Drp1
flx/flx
 mice were a gift from Katsujoshi Mihara (Ishihara et al., 2009). The CamKIIalpha CreERT2 
mouse was purchased from the European Mouse Mutant Archive (EMMA strain 02125) (Erdmann et 
al., 2007). At 8 weeks of age mice were injected i.p. with 1 mg Tamoxifen (10 mg/ml Tamoxifen, 
Sigma T5648 in 9:1 sunflower seed oil to ethanol) twice per day on five consecutive days to induce 
Drp1 locus recombination. Experiments were performed in compliance with protocols approved by the 
local Basel Committee for Animal Care and Animal Use. Mice were terminally anaesthetized with an 
intraperitoneal injection of 10 mg/kg ketamine and 20 mg/kg xylazil followed by 250 mg/kg tiopenthal. 
Behavior  
For all of the following behavioral tests mice were brought into a separated testing room with dim 
illumination and left to habituate for 2 h before any procedure began. Visual Performance was tested 
in the Morris Walter tank with a visible platform. Each mouse was placed on a flagged squared 
platform (15 cm wide) located in the centre of the South-east quadrant into the water-tank (150 cm 
diameter) and let to observe the environment for two minutes. The tank was filled with water kept at 
28°C. Thirty minutes later each mouse was released from four different starting points: south, west, 
north and east in that order. Latencies to reach the visible platform were scored. Cut-off time was two 
minutes. Olfaction was tested using the cookie finding test. Each mouse was temporary taken away 
from his home cage and a food pellet of 0.8-1.0 grams was buried under the sawdust layer, invisible to 
the naked eye. The position of the pellet was at the centre of the southern part of the cage, away from 
corners. Then each mouse was returned to his home cage and the latency to find the pellet was 
scored. To score hippocampus-dependent working memory the spontaneous alternation task was 
employed based on the spontaneous alternation paradigm (Ragozzino et al., 1996). A standard 8- 
arm, radial maze for mice was employed. Four out of the eight arms were kept open only, in the way to 
form a cross. Each mouse was singly released in the central hub and left free to explore for 10 
minutes. Arm-entry number and sequence were scored (arms were named as A, B, C and D). A 
correct alternation was considered when mice made one-repetition only over five entries (A, B, D, C, D 
is correct while A, B, C, B, A is not). 
Histology and immunohistochemistry 
Anaesthetized mice were killed by transcardial perfusion with 20 ml of cold PBS followed by 20 ml of 4 
% Formaldehyde in PBS ph 7.4. Brain and interscapular white and brown adipose tissue were 
dissected and post-fixed overnight. Following paraffin embedding 10- m, coronal cross sections were 
prepared. A haematoxylin and eosin staining (H&E) was performed for the morphological analysis of 
the adipose tissue. Brain sections were deparaffinized and immersed in 95°C citrate buffer ph 6 for 15 
min. Sections were blocked with 15% normal goat serum (NGS) for 1h and subsequently incubated 
with cytochrome c oxidase subunit1a antibody (abcam ab14705, 1:200) at 4°C overnight and mouse 
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AF488 (Molecular Probes A11029; 1:1000). Slides were mounted with Prolong Gold antifade mounting 
solution containing DAPI (Life Technologies). Cross sections representing the coordinates bregma (-
1.34) – (-2.46) were selected and z-stacks were recorded with an inverted Zeiss Axiovert 200M LSM 
510 Meta confocal microscope with a 100x/1.4 Oil DIC objective using Enterprise 405 nm and Argon 
488 lasers. Z-stacks were projected onto a single plane using ImageJ.  
Golgi staining was performed on PBS-perfused, unfixed brains using a commercial kit (Rapid 
GolgiStain Kit; FD Neurotechnologies; PK401). Camera lucida drawings were analysed with the Sholl 
Analysis tool of ImageJ.  
Synapse number was quantified as described in (Ippolito and Eroglu, 2010), shortly we stained 
coronal cross sections of mouse brains with a presynaptic marker VGLUT2 (Millipore; AB2251; 
1:1000) and a postsynaptic marker PSD95 (Novex; 51-6900; 1:100). The corresponding secondary 
antibodies were anti guinea pig AF488 (Molecular Probes; A-11073; 1:1000) and anti-rabbit AF594 
(Molecular Probes; A-11012; 1:1000): The number of colocalizing punctae within a 150 μm x 150 μm x 
5 μm confocal image stack (for microscope configuration see above) was analyzed using ImageJ. 
Four of these image stacks were recorded per animal within the coordinates bregma (-1.34) - -(2.46). 
An imaginary vertical line was drawn along the open end of the arrow shaped structure of the granule 
nuclei of the dentate gyrus towards the stratum radiatum where a z-stack was recorded.  
Hippocampal volume was calculated from H&E stained 100 μm-spaced, serial, coronal cross sections 
applying the Cavalieri principle. For the Cortical and the midbrain volume we only considered the 
sections representing coordinates bregma 1.1 – (-1.2) using the corpus callosum as a reference. 
Transmission Electron Microscopy 
Anaesthetized mice were killed by transcardial perfusion with 20 ml of cold PBS followed by 20 ml of 1 
% Gluteraldehyde in 0.1 M Cacodylate buffer ph 7.4. The hippocampus was dissected and post fixed 
for 1 week. Hippocampi were then stained with OsO4 and embedded in epoxide resin. Semithin 
sections were prepared to localize the nuclear bands of the hippocampus of which ultrathin sections 
were prepared that were collected onto a mesh grid and imaged with a Phillips CM100 transmission 
electron microscope. Morphological analysis of ER and mitochondria was performed using ImageJ. 
The minimal radial diameter of a mitochondrion was calculated using the rotating calipers algorithm 
(http://doube.org/files/RotatingCalipers.txt) and the roundness of rER structures was calculated using 
the standard shape descriptors of ImageJ. The mitochondria and ER structures in the perikarya of in 
average 80 hippocampal neurons were analyzed per animal. Criteria for the identification of synapses 
were a postsynaptic electron dense area and presynaptic vesicles. 
Electrophysiology 
Twelve-week-old Drp1
flx/flx 
Cre
+
 and control mice (4 weeks after tamoxifen treatment) were 
anaesthetized with isoflurane (4% in O2, Vapor, Draeger) and killed by decapitation. In order to 
increase cell viability, animals were exposed to oxygen-enriched atmosphere for 10 min prior to 
decapitation. Transverse 350 to 400-m-thick hippocampal brain slices were cut using a Leica VT1200 
Vibratome (Bischofberger et al., 2006; Geiger et al., 2002). For cutting and storage, a sucrose-based 
solution was used, containing (in mM): 87 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 75 sucrose, 0.5 
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CaCl2, 7 MgCl2 and 10 glucose (equilibrated with 95% O2/ 5% CO2). Slices were kept at 35°C for 30 
min after slicing and subsequently stored at room temperature until experiments were performed. 
During electrophysiological recordings, slices were continuously superfused with artificial 
cerebrospinal fluid (ACSF) containing (in mM: 125 NaCl, 25 NaHCO3, 25 glucose, 3 KCl, 1 NaH2PO4, 
2 CaCl2, and 1 MgCl2; equilibrated with 95% O2/ 5% CO2) at 32-33 ºC.  
Whole-cell, patch-clamp recordings were obtained from hippocampal CA1 pyramidal neurons using 
patch pipettes (resistance of 3-6 MΩ) pulled from borosilicate glass tubing with 2.0 mm outer diameter 
and 0.5 mm wall thickness (Hilgenberg, Malsfeld, Germany; Flaming-Brown P-97 puller, Sutter 
Instruments, Novato, USA). Patch-pipettes were filled with a solution containing (in mM): 135 K 
gluconate, 20 KCl, 10 HEPES, 2 MgCl2, 2 Na2ATP, 0.3 NaGTP, 0.1 EGTA, and 0.2% biocytin adjusted 
to pH 7.3-7.4 with NaOH. To evaluate cellular properties and excitability 1-s-long current steps of 
increasing amplitude (steps of 25 pA) were injected.  
Field excitatory postsynaptic potentials (fEPSP) were recorded with glass pipettes filled with 1 M NaCl 
(resistance of 3-5 MΩ) placed in the stratum radiatum of the CA1 region. The bipolar tungsten 
stimulating electrode (Stereotrodes, World Precision Instruments, Inc.) was placed ~500 µm away to 
stimulate the Schaffer collaterals (SC; 200-400 µA). To restrict the fEPSP to AMPA receptor-mediated 
currents, 25 µM of the NMDA receptor antagonist AP5 (D-(-)-2-amino-5-phosphonopentanoic acid) 
were added to the bath solution. SC inputs were evoked at 0.1 Hz. To challenge synaptic transmission 
100 stimuli were applied either at 10 or at 100 Hz. 
Voltage signals were measured with a Multiclamp 700A amplifier (Molecular Devices, Palo Alto, CA, 
USA), low-pass filtered with cut-off frequencies of 10 kHz for whole-cell patch-clamp and 2 kHz for 
fEPSP recordings, respectively, and digitized at 20 kHz using a CED Power 1401 interface 
(Cambridge Electronic Design, Cambridge, UK). Bridge balance was used to compensate the series 
resistance (RS = 10-30 MΩ) in current clamp recordings. Data acquisition was controlled by custom 
software (FPulse, U. Fröbe, Physiological Institute Freiburg) running under IGOR Pro 6.31 
(WaveMetrics, Lake Oswego, Oregon). 
During the recording, neurons were filled with biocytin. At the end of the recording, the pipette was 
carefully removed from the neuron to avoid rupture of the membrane. Following the successful pipette 
removal, indicated by the formation of an outside-out patch, the brain slice was stored another 30 min 
in ACSF to allow for sufficient time for the diffusion of biocytin. Brain slices were fixed overnight in 4% 
paraformaldehyde and then incubated overnight with 0.3% triton X-100 and avidin, Fluorescein 
conjugate (1:500; Invitrogen). After washing, the slices were embedded in Prolong Gold (Invitrogen). 
Fluorescence labeling was analyzed with a confocal laser scanning microscope (LSM 700, Zeiss). 
Data analysis was performed offline using customized scripts written in python and the open source 
analysis software Stimfit (http://code.google.com/p/stimfit C. Schmidt-Hieber, University College 
London). To evaluate the facilitation of fEPSPs during high-frequency stimulation, four subsequent 
waveforms were averaged and the strength of synaptic transmission was measured as the fEPSP 
slope. A linear fit to the fEPSP was calculated for a window of 1-ms length sliding over the ascending 
phase of the fEPSP after the initial fiber volley and the maximal value was recorded.  
Manuscript -56 
Preparation of isolated mitochondria. 
Cortex and hippocampus were quickly dissected on ice and washed in an ice-cold buffer (210 mM 
mannitol, 70mM sucrose, 10 mM HEPES, 1 mM EDTA, 0.45% BSA, 0.5 mM DTT, and Complete 
Protease Inhibitor mixture tablets (RocheDiagnostics). The tissue samples were homogenized in 2 ml 
of buffer with a glass homogenizer (10–15 strokes, 400 rpm). 10 μl of the suspension was used for 
protein determination. All cortex and hippocampus homogenate samples were normalized on 1.5 
mg/ml before ROS measurement. 
Mitochondria were isolated from cortex and hippocampus as previously described (Rhein et al., 2009). 
Briefly, mice were killed by decapitation, and cortex and hippocampus were quickly dissected on ice 
and washed in an ice cold buffer (210 mM mannitol, 70mM sucrose, 10 mM Hepes, 1 mM EDTA, 0.45 
% BSA, 0.5 mM DTT, and Complete Protease Inhibitor mixture tablets (RocheDiagnostics). The tissue 
sample was homogenized in 2 ml of buffer with a glass homogenizer (10–15 strokes, 400 rpm), and 
the resulting homogenate was centrifuged at 1400 x g for 7 min at 4 °C to remove nuclei and tissue 
particles. The low-speed centrifugation step was repeated once with the supernatant. Then, the 
supernatant fraction was centrifuged at 10000 x g for 5 min at 4 °C to pellet mitochondria. The 
resulting pellet was resuspended in 1 ml of ice cold buffer and centrifuged again at 1400 x g for 3 min 
at 4 °C. Finally, the mitochondria-enriched supernatant was centrifuged at 10000 x g for 5 min at 4 °C 
to obtain a mitochondrial fraction. This fraction was resuspended in 300 ul of PBS and kept at 4 °C 
until use. 10μl of the suspension were used for protein determination. All isolated mitochondria 
samples were normalized on 1mg/ml of protein before ATP content determination and 5ug / 50 μl 
before oxygen consumption rate (OCR) measurements. 
ATP measurement 
ATP content from isolated mitochondria was determined using a bioluminescence assay (ViaLighTM 
HT; Cambrex Bio Science) according to the manufacturer’s instructions. The enzyme luciferase, which 
catalyzes the formation of light from ATP and luciferin was used. The emitted light is linearly related to 
the ATP concentration and is measured using the luminometer VictorX5 (Perkin Elmer).  
Oxygen consumption rate measurements 
Oxygen consumption rate was measured in isolated mitochondria from cortex and hippocampus using 
a Seahorse Bioscience XF24Analyzer, following the recommendation of the company. Briefly, 
mitochondria were first diluted 10X in cold 1X Mitochondrial Assay Solution (MAS; 70 mM sucrose, 
220 mM mannitol, 10 mM KH2PO4,5 mM MgCl2, 2 mM HEPES, 1 mM EGTA and 0.2% (w/v) fatty acid-
free BSA, pH 7.2 at 37°C) containing 10 mM Succinate, 2 mM Malate and 10 mM Pyruvate. 50 μL of 
mitochondrial suspension was delivered to each well of a XF Cell Culture microplate (except for 
background correction wells) and centrifuged at 2000 x g for 20 minutes at 4°C. After centrifugation, 
450 μL of pre-warmed (37°C) 1X MAS + substrate was added to each well and the plate was 
incubated 5 min at 37°C in a CO2-free incubator prior to the experiment. The plate containing isolated 
mitochondria was placed in a XF24 Analyzer and oxygen consumption rate was evaluated under 
different respiratory states. The experiment started in a coupled state in the presence of succinate, 
pyruvate and malate. State 3 was initiated following the injection of 55 μl of 40 mM ADP (4 mM final). 
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State 4o was induced with the addition of 62 μl of 25 μg/ml oligomycin (2.5 μg/ml final) and State 3 
uncoupled (3u) was assessed after injection of 68 μl 40 μM FCCP (4 μM final) before shutting down 
mitochondrial respiration by injecting 76 μl of 40 μM and 20 μM (4 μM and 2 μM final) of antimycin A 
and rotenone respectively.  
Metabolic measurements 
Metabolic parameters were measured by CLAMS (Columbus Instruments). After a 48 h acclimatization 
4-week-Drp1-ablated and control mice were monitored for 72 h. Mouse body compostion was 
monitored with an EcoMRI-100 qNMR (EchoMRI Medical Systems). For the i.p. glucose tolerance test 
mice (10 weeks post tamoxifen injection) were starved overnight and 2g/kg glucose was injected i.p. 
Blood glucose was monitored in tail vein blood using Accu Check Aviva test strips (Roche). For the 
insulin tolerance test we injected 7.5 U/kg insulin (Actrapid Human Insulin A10AB01 100U/ml) i.p. and 
monitored tail vein blood glucose concentration accordingly. 
Real-time PCR 
Organs were collected from PBS perfused mice and RNA was isolated using Qiagen kits (RNeasy 
Lipid Tissue Kit for adipose tissue; 74804, RNeasy Fibrous Tissue kit for muscle; 74704 and RNeasy 
kit for other organs 74104 ). Reverse-Transcriptase PCR was performed using the High Capacity 
cDNA Reverse Transcription Kit (Invitrogen; 4368814). Real-time PCR was performed using TaqMan 
assays (Life Technologies) on a 7900HT Real-Time PCR System (Applied Biosystems). The following 
TaqMan assays were used: FGF21 (Mm00840165_g1), 18S (Mm03928990_g1), Chop 
(Mm01135937_g1), PPARα (m00440939_m1), PPARδ (Mm00803184_m1), PGC-1α 
(Mm01208835_m1), PGC-1β (Mm00504720_m1), ATF4 (Mm00515325_g1), Akt1 
(Mm01331626_m1), PI3K (Mm00803160_m1). Cross-threshold (Ct) values were normalized to 18S Ct 
values. 
Western Blot 
Brains of perfused mice were dissected and lysates were prepared in RIPA Buffer (150mM NaCl; 1 % 
IGEPAL; 0.5 % sodium deoxycholate acid; 0.1 % sodium dodecyl sulfate; 50 mM Tris pH8) containing 
a protease inhibitor cocktail (Sigma; P83450) and phosphatase inhibitor (Roche; 04906837001). Brain 
extracts were run on 4-12 % BisTris SDS-PAGE gels and blotted onto nitrocellulose membranes using 
the iBlot Dry Blotting System (Life Technologies). Membranes were probed with the following 
antibodies: Drp1 (BD Biosciences, 611112), ATF4 (Santa Cruz, sc-200), Bip (BD Biosciences, 
610978), Akt1 (Cell Signaling, 9272), Akt1-P S473 (Cell Signaling, 4060), actin (Thermo Scientific; 
MA1-91399). The secondary antibodies were anti mouse-HRP (GE Healthcare; NA931) and anti rabbit 
(GE Healthcare; NA934) and for signal detection Amersham ECL Prime Western Blotting Detection 
Reagent (GE Healthcare; RPN2232) was used in conjunction with Amersham Hyperfilm (GE 
Healthcare; 28-9068-44). For the detection of carbonylated protein the guidelines of the OxyBlot 
Protein Oxidation Detection Kit (Millipore; S7150) were followed. 
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ELISAs and colorimetric assays 
Blood was collected between 9 and 10 am and hormone levels were detected by ELISA from either 
serum: Corticosterone (Arbor Assays; K014-H1), T4 (Callbiotech; t4044T-100), or plasma: Leptin 
(BioVendor, RD291001200R), Ghrelin (Millipore, EZRGRA-90K), FGF21 (BioVendor; 
RD291108200R). 
Brains were dissected from PBS perfused mice and homogenates were prepared according to the 
protocols of the following kits: TBARS (Cayman Chemicals; 10009055-96), Glutathione (Cayman 
Chemicals; 703002-96) 
Fluorescent ROS probes 
The formation of mitochondrial reactive oxygen species (ROS) and superoxide anion radicals in 
cortical and hippocampal homogenates was measured using the fluorescent probes 
dihydrorhodamine-123 (DHR) (Sigma) and the Red Mitochondrial Superoxide Indicator MitoSOX 
(Molecular probes) respectively. Sample homogenates were loaded for 15 min with 10 μM DHR or 75 
min with 5 μM MitoSOX at room temperature in the dark on an orbital shaker. After washing twice with 
HBSS (Sigma), DHR, which is oxidized to cationic rhodamine 123 localized within the mitochondria 
and exhibits a green fluorescence, was detected using the VictorX5 multilabel reader (PerkinElmer) at 
Ex: 485 nm / Em: 535 nm. MitoSOX, which is specifically oxidized by mitochondrial superoxide and 
exhibits a red fluorescence, was detected at Ex: 535 nm / Em: 595 nm. The intensity of fluorescence 
was proportional to the level of reactive oxygen species. 
 
Manuscript - 59 
Supplemental References 
Bischofberger, J., Engel, D., Li, L., Geiger, J.R., and Jonas, P. (2006). Patch-clamp recording from 
mossy fiber terminals in hippocampal slices. Nat. Protoc. 1, 2075–2081. 
Erdmann, G., Schutz, G., and Berger, S. (2007). Inducible gene inactivation in neurons of the adult 
mouse forebrain. BMC Neurosci 8, 63. 
Geiger, J.R.P., Bischofberger, J., Vida, I., Fröbe, U., Pfitzinger, S., Weber, H.J., Haverkampf, K., and 
Jonas, P. (2002). Patch-clamp recording in brain slices with improved slicer technology. Pflüg. Arch. 
Eur. J. Physiol. 443, 491–501. 
Ippolito, D.M., and Eroglu, C. (2010). Quantifying Synapses: an Immunocytochemistry-based Assay to 
Quantify Synapse Number. J. Vis. Exp. 
Ragozzino, M.E., Unick, K.E., and Gold, P.E. (1996). Hippocampal acetylcholine release during 
memory testing in rats: augmentation by glucose. Proc. Natl. Acad. Sci. U. S. A. 93, 4693–4698. 
Rhein, V., Song, X., Wiesner, A., Ittner, L.M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., 
Dröse, S., Brandt, U., et al. (2009). Amyloid-β and tau synergistically impair the oxidative 
phosphorylation system in triple transgenic Alzheimer’s disease mice. Proc. Natl. Acad. Sci. 106, 
20057–20062. 
 
Manuscript -60 
Supplemental Figure Legends 
Figure S1 Drp1-ablated mice display a lethal metabolic phenotype 
(A) Visual performance of 4-week-Drp1-ablated and control mice was tested in the Morris Walter tank 
with a visible platform. Data represent average ±SEM of at least 7 animals. 
(B) Olfaction of 4-week-Drp1-ablated and control mice was tested using the cookie finding test. A 
cookie was placed inside the mouse`s cage and the time until the cookie was found was measured. 
Data represent average ±SEM of at least 7 animals. 
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Figure S2 Parameters of Drp1-ablated mitochondria 
(A+B) 4-week-Drp1-ablated and control mice were injected i.p. twice daily for 5 consecutive days with 
1mg of tamoxifen, and sacrificed 4 weeks after the last tamoxifen injection. Coronal sections of 
formalin-fixed paraffin-embedded (FFPE) brains were immuno-stained for cytochrome c oxidase 
subunit 1 (green) and with DAPI (blue). Images show CA4 pyramidal neurons (A) and granule cell 
neurons of the dentate gyrus (B). White scale bar represents 10 µm. 
(C) Oxygen consumption rate of isolated, cortical mitochondria of 4-week-Drp1-ablated and control 
mice was measured with a Seahorse Bioscience XF24 Analyzer. Substances were injected at the 
indicated time points. Data represent average ±SEM of at least 4 animals whose cortices were pooled 
and the measurements were performed with at least 6 replicates. 
(D) ATP content of isolated, cortical mitochondria of 4-week-Drp1-ablated and control mice was 
measured with a bioluminescence assay. Data represent average ±SEM of at least 4 animals whose 
cortices were pooled and the measurements were performed with at least 8 replicates. 
(E+F+G) Mitochondrial membrane potential of isolated, cortical mitochondria of 4-week-Drp1-ablated 
and control mice was measured by the increase of the fluorescence caused by the accumulation of the 
indicated dyes. Data represent average ±SEM of at least 4 animals whose cortices were pooled and 
the measurements were performed with at least 4 replicates. 
(H) Oxidative stress levels represented by DHR and MitoSox fluorescence in cortical tissue 
homogenate of 4-week-Drp1-ablated and control mice. Data represent average ±SEM of at least 4 
animals whose cortices were pooled and the measurements were performed with at least 4 replicates. 
(I) Thiobarbituric acid reactive substances (TBARS) levels - representing lipid peroxidation - in 4-week-
Drp1-ablated and control cortical lysates were measured by commercial fluorescence kits. Data 
represent average ±SEM of at least 6 animals. 
(J) 4-week-Drp1-ablated and control cortical lysates were separated by SDS-PAGE and 
immunoblotted using an antibody for carbonylated protein of a commercial oxyblot kit. Data represent 
average ±SEM of at least 4 animals. 
Asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. 
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Figure S3 Drp1 ablation induces morphological ER alterations and ER stress 
(A) Representative Western blot of Drp1-ablated and control cortical lysates which were separated by 
SDS-PAGE and immunoblotted using the indicated antibodies. 
(B+C) Quantification of ATF4 and Bip band intensity normalized to actin. Data represent average 
±SEM of at least 4 animals. 
(D) Quantification of phosphorylated elF2α band intensity normalized to total elF2α. Data represent 
average ±SEM of at least 4 animals. 
Asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001. 
Manuscript - 63 
 
Figure S4 Drp1 ablation does not lead to neurodegeneration but leads to impaired synaptic 
transmission 
(A) fEPSPs were recorded in the CA1 stratum radiatum in 4-week-Drp1-ablated and control 
hippocampal slice cultures after stimulating the Schaffer collaterals. Mean slope of fEPSPs during the 
time course of a 100Hz stimulation. Data represent average ±SEM of at least 6 neurons. 
(B) Maximal mean fEPSP slope after 100 Hz stimulation. Data represent average ±SEM of at least 6 
neurons. 
Asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, 
***:P<0.001.
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Figure S5 Drp1 ablation in the forebrain induces metabolic shift transmitted by Fgf21 
(A+B+C+D+E) 4-week-Drp1-ablated and control animals were housed in metabolic cages and their 
ambulatory activity, drinking, food intake and their respiratory gas exchange was monitored. The latter 
was used to calculate metabolic rate and respiratory exchange ratio. Data represent average ±SEM of 
at least 8 animals. 
(F+G) Leptin and active ghrelin plasma levels in cardiac blood of 10-week-Drp1-ablated and control 
animals were determined by ELISA. Data represent average ±SEM of at least 5 animals  
(H) Glucose tolerance test in 10-week-Drp1-ablated and control animals. Animals were starved 
overnight and injected with 2g/kg glucose and their glucose blood levels were monitored for the 
indicated time points. Data represent average ±SEM of at least 7 animals. 
(I) Insulin tolerance test in 10-week-Drp1-ablated and control animals. Animals were starved overnight 
and injected with 7.5 U/kg insulin and their glucose blood levels were monitored for the indicated time 
points. Data represent average ±SEM of at least 5 animals.  
(J) RNA was isolated from hippocampus from 10-week-Drp1-ablated and control animals. RNA was 
retrotranscribed into cDNA and a qRT-PCR performed using the TaqMan system. Indicated mRNA ct 
values were normalized against 18S rRNA ct values. Data represent average ±SEM of at least 4 
animals.  
(K) Representative Western blot of 10-week-Drp1-ablated and control hippocampal lysates which were 
separated by SDS-PAGE and immunoblotted using the indicated antibodies. 
(L) Quantification of phosphorylated S473 Akt1 band intensity normalized to total Akt1. Data represent 
average ±SEM of at least 4 animals. 
Asterisks denote P-values of an unpaired, two-tailed Student`s t-test: *:P<0.05, **:P<0.01, ***:P<0.001
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Supplementary Figures 
Figure S1 Drp1-ablated mice display a lethal metabolic phenotype 
 
Manuscript -66 
Figure S2 Parameters of Drp1-ablated mitochondria 
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Figure S3 Drp1 ablation induces morphological ER alterations and ER stress 
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Figure S4 Drp1 ablation does not lead to neurodegeneration but leads to impaired synaptic 
transmission 
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Figure S5 Drp1 blation in the forebrain induces metabolic shift transmitted by Fgf21 
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General Discussion  
Dysregulated mitochondrial morphology has been implicated in a number of neurodegenerative 
diseases. In mouse models, the genetic knockout of essential mediators of mitochondrial fusion and 
fission results in early embryonic lethality, reflecting the physiological importance of properly regulated 
mitochondrial dynamics. The fission-mediating protein Drp1 is known as a double-edged sword. It can 
actively drive neurodegeneration under some conditions, and - at the same time - be essential for 
neuronal development and neuronal stability. Ablation of Drp1 is reported to lead either to a 
neuroprotective superelongated (Figure 3B) (Barsoum et al., 2006; Cheung et al., 2007; Costa et al., 
2010; Dagda et al., 2008; Meuer et al., 2007; Tian et al., 2009; Young et al., 2010; Yuan et al., 2007) 
or an aggregated mitochondondrial phenotype (Figure 3C) promoting neurodegeneration (Ishihara et 
al., 2009; Li et al., 2004; Uo et al., 2009; Wakabayashi et al., 2009; Wang et al., 2009). From 
previously published models it had remained unclear in how far Drp1-induced neurodegeneration 
might be caused by a defect during neuronal differentiation due to the absence of Drp1. In order to by-
pass neuronal defects caused by Drp1 ablation we developed a model that allowed us to ablate Drp1 
in adult, postmitotic neurons in vivo. The first aim of this thesis was to dissect the role of Drp1 during 
neurodevelopment from its role in regulating health and death of adult neurons.  
In vitro, in primary cortical neurons we could demonstrate that the two types of neuronal mitochondrial 
morphology reported in the literature represent two sequential stages. The initial phase (1-3 days after 
Drp1 ablation), characterized by a superelongated mitochondrial network, is transitory and gives way 
to the final stage where Drp1 ablation results in the collapse of the organelles into large spheres that 
aggregate in the neuronal perikarya (6-9 days after Drp1 ablation).  
However, in vivo, we could recapitulate only this second aggregated organellar morphology but failed 
to observe clearly superelongated mitochondria. This superelongated phenotype was reported in 
Purkinje neurons in vivo at one week after Drp1 ablation (Kageyama et al., 2012) and in CA1 
pyramidal neurons expressing mutant tau, which disrupts actin and subsequently causes Drp1 
translocation to mitochondrial fission sites (DuBoff et al., 2013). It thus appears that the 
superelongated mitochondrial phenotype may occur in vivo, and our in vitro results suggest that 
mitochondrial aggregation should be preceded by elongation of the organelles. We think that this 
discrepancy is based on experimental reasons: in our mice, mitochondria around the nuclei of wildtype 
pyramidal neurons are already quite long, and in order to convincingly pinpoint a superelongated 
phenotype one would need to be able to trace single mitochondria reaching into the dendrites. 
However, due to the nature of the staining, it is impossible to accurately measure mitochondrial length 
in the soma and to trace single dendritic mitochondria. Given the time of maximum reduction of Drp1 
protein levels (10 d) and the occurrence of the first mitochondrial blebs (also 10 d), we would expect 
mitochondria to pass the superelongated stage at an earlier timepoint after Drp1 ablation. In future 
experiments, we will therefore address this question by crossing our mouse line with a reporter strain 
that we recently obtained and which expresses a Cre recombinase-activatable mYFP. Titrating the 
dose of tamoxifen would allow us to induce a mosaic pattern of Cre activity in the forebrain which 
should allow tracing mitochondria of single neurons (Bersell et al., 2013). Another approach might be 
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to co-stain coronal brain sections for mitochondria and β-tubulin. β-tubulin staining would aid in 
identifying dendrites with the same orientation as the tissue section cutting plane, and only 
mitochondria associated with dendritic structures would be measured (Kopeikina et al., 2011).  
 A number of recent publications have shown that treatment with the Drp1 inhibitor mdivi-1 reduces the 
infarct area in various models of ischemia (Grohm et al., 2012; Park et al., 2011; Zhang et al., 2013). 
However, off-target effects of this (and other published) Drp1 inhibitors cannot be excluded. For 
example, mdivi-1 inhibits Bax-stimulated cytochrome c release from isolated mitochondria that cannot 
undergo fission (Cassidy-Stone et al., 2008). It is also likely that those inhibitors do not suppress all 
Drp1 functions: Inhibitor-bound Drp1 might, for instance, still be able to translocate to mitochondria or 
other cellular membranes and be subjected to posttranslational modifications. Also, no survival 
problems have been reported for mice treated continuously for three months with a Drp1 inhibitor, 
while our mice die within the same time period after Drp1 ablation (Guo et al., 2013b). In order to 
answer the question whether the beneficial effects of Drp1 inhibitors under ischemic conditions really 
result from Drp1 inactivation, we will have to repeat our MCA-O experiments one week after Drp1 
ablation, when we expect the mitochondria to be elongated. We will additionally try to dose Drp1 levels 
by heterozygously deleting Drp1, which is well tolerated and has no apparent phenotype (Manczak et 
al., 2012). 
The second aim of the thesis was to test the effect of long-term Drp1 ablation on neuronal function.  
Our experiments revealed that mitochondria in long-term Drp1 ablated neurons are not only much 
larger than in wildtype neurons but also loose part of their cristae structure. Curiously, Drp1 inhibition 
has been shown to inhibit cristae remodeling in certain apoptotic settings (Costa et al., 2010; Germain 
et al., 2005), while Drp1 ablation-induced aggregation of mtDNA nucleoids is characterized by empty 
inner mitochondrial space (Ban-Ishihara et al., 2013). We assume that the observed disruption of 
cristae structures at least partly results from nucleoid aggregation; but we also observed a large 
amount of mitochondrial cross sections entirely devoid of cristae, which is different from the TEM 
images published by Ban-Ishihara and co-workers (Ban-Ishihara et al., 2013). Thus, most likely, 
additional mechanisms regulating mitochondrial ultrastructure are affected by Drp1 loss. Not 
surprisingly, Drp1 ablated mitochondria have a less sufficient respiratory capacity and accumulate less 
ATP than control mitochondria. Based on enzyme-histochemical stainings of respiratory complexes, 
similar observations have been made by Kageyama et al. in Drp1 ablated Purkinje neurons 
(Kageyama et al., 2012). Kageyama and coworkers observe that within 5 weeks after Drp1 ablation 
the number of Purkinje cells is decreased, which can partially be rescued by antioxidant treatment. Of 
note, at 4 weeks after Drp1 ablation, we were not able to detect any ROS formation or 
neurodegeneration in our model. Nevertheless (and quite unexpectedly) our mice died around 12 
weeks after Drp1 ablation for reasons that will be discussed further below. At this point, we cannot 
exclude that oxidative stress and neurodegeneration could in fact be detected in our model at later 
timepoints if our mice lived longer. 
While we did not detect any ROS stress during the first 4 weeks following Drp1 ablation, we did find 
substantial evidence for ER stress. During ER stress the chaperone Bip detects unfolded proteins 
inside the ER lumen and activates of a number of subpathways. One of them is initiated by the 
autophosphorylation of the integral ER membrane protein pancreatic eIF2α kinase (PERK). PERK 
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phosphorylates eukaryotic initiation factor 2α (eIF2α) which induces activating transcription factor 4 
(ATF4). ATF4, in turn, activates the transcription of a myriad of genes, among them DNA damage 
inducible transcript 3 (Ddit3). The translation product of Ddit3, also known as Chop, acts as a 
dominant dimerization protein for transcription factors of the C/EBP family and promotes apoptosis. On 
mRNA as well as protein level, we find ample evidence for the activation of the PERK-mediated ER 
stress pathway which is paralleled by substantial changes in ER morphology in Drp1-ablated neurons.  
In a model of angiotensin-II-induced chronic hypertension neuronal ER stress is associated with 
similar ER morphology changes reflecting that neuronal ER stress and ER shape are interconnected 
(Young et al., 2012). However, particularly in neurons, ER fragmentation seems to be a reversible 
phenomenon in response to insults not necessarily connected to ER stress (Kucharz et al., 2013), and 
thus it is possible that ER fragmentation per se is part of an general adaptive stress response. The 
origin of the stress in our Drp1 ablation model could also be due to mitochondrial stress caused by 
respiratory deficiency and associated changes in mitochondrial morphology. Alternatively, as we 
detect eIF2α phosphorylation prior to Bip upregulation, eIF2α could also get phosphorylated by the 
kinase GCN2, which is activate during amino acid deprivation (Donnelly et al., 2013). 
ER and mitochondrial network are tightly interconnected by membrane structures called mitochondria 
associated ER membranes (MAMs). Disruption of MAMs by mutant α-synuclein disrupts ER-
mitochondria interorganellar connections, and induces Drp1-independent fragmentation of 
mitochondria (Guardia-Laguarta et al., 2014). Likewise, MAMs disruption by deletion of Mfn2, which 
interconnects ER and mitochondria, induces fragmentation of both organelles (de Brito and Scorrano, 
2008). Hence, it seems very likely that profound morphological changes of one organelle inevitably 
impinge on the morphological integrity of the other. Mfn2-deficient cells also show UPR activation 
(Muñoz et al., 2013), indicating that disruption of trans-organelle connections is sufficient to induce ER 
stress. It was previously shown that Drp1 also localizes to the ER and can mediate ER morphological 
changes (Pitts et al., 1999; Wikstrom et al., 2013) indicating that Drp1 may directly regulate ER shape. 
Neurons that have an aggregated mitochondrial phenotype show a reduction in dendritic and synaptic 
structures in vitro (reviewed in Oettinghaus et al., 2012). However, as discussed before, we could not 
show that in our in vivo model. Even though they have to cope with decreased oxidative 
phosphorylation, ER stress, and are more sensitive to ischemia, Drp1 ablated pyramidal CA1 neurons 
have a regular dendritic tree morphology as well as regular synapse and spine numbers; in addition, 
no neurodegeneration is observed within 10 weeks of Drp1 ablation. In contrast, Drp1 ablated Purkinje 
neurons undergo neurodegeneration within 5 weeks after Drp1 ablation (Kageyama et al., 2012). As 
pointed out earlier, Drp1 is of particular importance for dendrite and synapse formation during 
neuronal development. In this context, it is interesting to note that murine Purkinje neuron 
differentiation continues during the first three weeks after birth (Chizhikov and Millen, 2003), and that 
the onset of Drp1 ablation in the Purkinje cell model of Kageyama and co-workers occurs at three 
weeks after birth. Therefore, one cannot exclude that Drp1 ablation overlaps with the final stages of 
Purkinje neuron differentiation, which might render them more susceptible to degeneration. In our 
model we can exclude neurodevelopmental defects caused by Drp1 ablation (tamoxifen knockout 
induction occurs at the age of 8 weeks), and our results show that dendritic and synaptic structures 
are largely unaffected by Drp1 ablation. We also find that basic functions are maintained in Drp1 
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ablated neurons: they generate action potentials, maintain their plasma membrane potential and are 
capable of synaptic transmission. However, numbers of presynaptic mitochondria are decreased and, 
when challenged by high frequency stimulation, synaptic transmission of Drp1 ablated neurons is 
impaired, indicating compromised neuronal function under certain conditions.  
Interestingly, a similar electrophysiological phenotype with a similar mitochondrial morphology has 
been observed at the neuromuscular junction of Drp1 mutant flies (Verstreken et al., 2005). While this 
phenotype has been attributed to ATP-dependent effects on reserve pool vesicle recycling due to the 
lack of mitochondria at the bouton, it has been shown more recently in murine hippocampal neurons, 
that Drp1 is also directly involved in reserve pool vesicle formation (Li et al., 2013). We think that the 
defect in synaptic transmission observed in our model is sufficient to explain the decrease in short-
term spatial working memory verified during behavioral testing of our Drp1 ablated mice.  
Finally, we observed a specific reduction in hippocampal volume which we believe is due to the nature 
of the metabolic phenotype characterized by increased circulating corticosterone. Hippocampal 
atrophy is a hallmark of post-traumatic stress disorder in which pathological stress hormone levels 
inhibit hippocampal neurogenesis (Bremner, 2006); therefore, testing whether Drp1 ablation effects 
hippocampal neurogenesis appears as a tempting hypothesis to be addressed by future 
experimentation. 
Our investigation of the long-term effects of Drp1 ablation on neuronal function was limited by the 
profound metabolic phenotype, invariably resulting in death of the animals within three months of Drp1 
ablation. In addition, we were also limited in all electrophysiological measurements because after the 
age of 3 months it becomes exceedingly difficult to prepare murine hippocampal slice cultures suitable 
for respective analyses. In particular, we cannot exclude that Drp1 ablation for longer than three 
months causes neurodegeneration. In order to address this, we will use Drp1
flx/flx
 mice expressing Cre-
activatable mYFP, and via tamoxifen titration induce Cre activity in only a few neurons, which might 
not be sufficient to cause the full-blown lethal phenotype. In these mice, the fate of mYFP expressing 
Drp1 ablated neurons can be monitored over time. 
We have not determined whether forebrain-Drp1 ablated mice also have a decrease in long-term 
memory. Long-term memory requires de novo spine formation in existing neuronal circuits, a process 
that is highly reliant on protein synthesis. Phosphorylation of elF2α, however, reduces the rates of 
mRNA translation, greatly impairing memory and contributing also to the cognitive impairment in AD 
(Costa-Mattioli et al., 2007; Ma et al., 2013). It thus appears likely, that the mice in our model also 
suffer from long-term memory impairment. In addition to extending our behavior experiments to test for 
long-term memory deficiency, we will therefore isolate polysomal fractions from Drp1 ablated brain 
tissue to check whether neurons in our model are subjected to translational arrest (Del Prete et al., 
2007). 
Our results also raise the question of whether Drp1 is directly involved in shaping the neuronal ER. As 
already discussed, Drp1 not only serves to induce mitochondrial fission but also interacts with a 
number of other cellular membranes including the ER. In the future, we will address this question by 
deriving neurons from Drp1
flx/flx 
mice expressing Cre-activatable mYFP, and co-electroporate them with 
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Cre and ERdsRed2 expression constructs to visualize the ER after Drp1 ablation. In addition, we will 
induce ER fragmentation via NMDA receptor activation as previously reported (Kucharz et al., 2009).  
Even though the ER shape of drp1 knockout embryonic fibroblasts (MEFs) was reported to be normal 
(Ishihara et al., 2009), unpublished results from our lab show that ER morphology changes after 
transfection of Drp1
flx/flx
 MEFs with Cre. We will generate Drp1
flx/flx
 MEFs stably expressing mYFP and 
ERdsRed2 to monitor mitochondrial and ER morphology after Drp1 ablation and under conditions of 
ER stress. Furthermore, we will generate a CFP-Drp1 fusion construct including versions with 
dominant-negative and phosphomimetic Drp1 mutations. This will allow us to directly monitor Drp1 
translocation to mitochondria and ER simultaneously in live cells. If possible, we will make use of 
superresolution microscopy to obtain precise colocalization imaging. We will also try to inhibit 
translocation of Drp1 to mitochondria by downregulating INF2 (Korobova et al., 2013) and by 
expressing P301L mutant tau (DuBoff et al., 2012). Once we have established a baseline of results 
and can genetically separate Drp1 translocation to ER and mitochondria, we will test whether 
treatment with the small molecule Drp1 inhibitor mdivi-1 blocks Drp1 function on ER and mitochondria, 
respectively.  
We also plan to recapitulate all of our findings in MEFs in primary neuronal cultures. To limit animal 
use, we have already derived a line of neural stem/progenitor cells (NSC) from WT mice. These cells 
can be propagated as progenitors and expanded, and then differentiated with appropriate stimuli and 
culture conditions to pure neuronal cultures. We will make use of this model to reduce animal numbers 
and to create neural stem progenitors stably expressing the above described constructs. 
Mice in which Drp1 translocation to mitochondria is inhibited by mutant tau can maintain a 
superelongated mitochondrial phenotype for up to seven months (DuBoff et al., 2012). We will 
purchase mice expressing transgenic P301L tau from the Jackson laboratory (stock No: 024854) to 
derive primary neuronal cultures in order to monitor ER and mitochondrial shape. Furthermore, we will 
cross these animals with Drp1
flx/flx
 Cre
+
 mice expressing Cre-activatable mYFP to see how additional 
deletion of Drp1 influences mitochondrial and ER shape. 
 
The third aim of this study was to investigate the metabolism of our mouse model. We find that Drp1 
ablation in the forebrain leads to a metabolic shift characterized by an increase in corticosterone 
levels. Corticosterone is the main glucocorticoid in rodents and has a variety of metabolic effects: it 
mobilizes energy stores by inducing lipolysis in fat tissue and by protein degradation in muscle, and it 
activates gluconeogenesis in the liver. Predominant in our mice was the effect on fatty acid 
metabolism. Despite normal feeding behavior, Drp1 ablated mice lost weight and had a decreased 
percentage of body fat.  
Corticosterone levels can be regulated via Fgf21 receptor binding in the hypothalamus (Bookout et al., 
2013) and accordingly, we find elevated Fgf21 plasma levels in forebrain-Drp1 ablated mice. We also 
find that Fgf21 mRNA expression is only increased in brain regions in which we ablated Drp1. 
Compellingly, forebrain-Drp1 ablated mice share a similar metabolic phenotype with Fgf21 
overexpressing mice regarding weight development, lower glucose levels, fat tissue histology and 
corticosterone levels (Bookout et al., 2013; Kharitonenkov et al., 2005; Zhang et al., 2012). In contrast, 
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however, mice overexpressing Fgf21 do not die but in fact have an extended life span, similar to mice 
fed a calorie-restricted diet (Zhang et al., 2012). While we do not have a definitive explanation for this 
phenotypic discrepancy, the difference between those two models could potentially be attributed to 
functionally impaired Drp1 ablated neurons, and to a difference in the physiological distribution of 
Fgf21. 
In our model the CamKIIα promoter that controls the CreERT2 transgene is also active in the 
paraventricular nucleus in the hypothalamus (Erdmann et al., 2007). It recently became apparent, that 
mitochondrial dynamics can also be involved in intraneuronal signal transduction. Changes of the 
morphology of the neuronal mitochondrial network can be a specific reaction to hormone or metabolite 
sensing in certain highly-specialized hypothalamic neuronal subpopulations (Carneiro et al., 2012; 
Dietrich et al., 2013; Schneeberger et al., 2013). At this point, we cannot exclude that Drp1 ablation 
affects hormone or metabolite sensing in this subset of neurons, and that this also contributes to the 
observed metabolic phenotype. β-klotho – a substantial component of the Fgf21 receptor – 
expression, however, is limited to the suprachiasmatic nucleus where the Cre-regulating promoter in 
our model is not active (Bookout et al., 2013).  
Fgf21 in our model is produced in close proximity to its hypothalamic receptor and induces 
corticosterone production as efficiently as systemic Fgf21 overexpression in mice which have a much 
higher Fgf21 levels. Fgf21 can cross the blood brain barrier via diffusion; however, degradation of 
Fgf21 in brain is 2-fold higher than in the serum (Hsuchou et al., 2007), indicating that some of the 
Fgf21 produced in brain might not reach Fgf21 receptors in the periphery. The activation of Fgf21 
receptors in adipose tissue is essential for the pharmacologically induced antidiabetic effects of Fgf21, 
in particular in lowering glucose concentrations and body weight (Luo and McKeehan, 2013). 
Transgenic mice with a respiratory deficiency in muscle tissue also induce Fgf21 to reach serum 
concentrations comparable to our model (Kim et al., 2013; Tyynismaa et al., 2010); however, the 
authors don`t state whether the Fgf21 produced in the periphery at these concentrations is sufficient to 
induce corticosterone production. The physiological role of Fgf21 is perceived as a metabolic stress 
hormone mediating inter-organ communication between stressed organ and adipose tissue, which 
induces a beneficial metabolic shift (Luo and McKeehan, 2013). It is thus very likely, that Fgf21 
production in Drp1 ablated brain is in fact beneficial to the organism and initiates a metabolic shift that 
supports Drp1 ablated brain regions and maintains their functionality. 
Collectively, through our work, we have characterized the basic mechanisms underlying the metabolic 
shift caused by forebrain-specific Drp1 ablation. Nevertheless, it remains unclear how Drp1 ablated 
neurons survive in vivo and how their metabolism changes due to the respiratory deficiency. The non-
glucose metabolites that can be used by neurons - lactate and ketone bodies - require oxidative 
phosphorylation, and it thus appears likely that Drp1 ablated neurons primarily rely on glycolysis. With 
this hypothesis in mind, we will perform future gene expression assays on glycolytic genes to verify 
our assumption.  
We also have not yet determined, how increased corticosterone and Fgf21 levels change metabolism 
in muscle and liver, where corticosterone could induce protein degradation (skeletal muscle) and 
gluconeogenesis (liver), respectively. We will therefore systemically measure skeletal muscle fiber size 
in various hindlimb muscles, as well as serum alanine concentration. In addition, we are going to 
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measure hepatic mRNA expression levels of genes regulating gluconeogenesis: PGC1α, pyruvate-
carboxylase and phosphoenolpyruvate-carboxykinase.  
The major novelty of this thesis work is that cortex and hippocampus can exert neuroendocrinological 
functions, signaling mitochondrial deficits via the UPR pathway to the periphery. To verify this 
hypothesis in vivo, we will treat Drp1 ablated mice and littermate controls with the FDA-approved 
chemical chaperone tauroursodeoxycholic acid (TUDCA), which reduces ER stress. We expect that 
this treatment will reduce eIF2α phosphorylation and thus Fgf21 levels, and will investigate whether 
this treatment is sufficient to normalize corticosterone levels and to rescue mitochondrial morphology. 
If indeed neuronal UPR signaling causes the metabolic shift in our mice, TUDCA treatment will either 
aggravate or ameliorate the metabolic phenotype depending on whether the Fgf21-induced change in 
metabolism is beneficial or harmful to the organsim. 
Fgf21 has recently been identified as biomarker for mitochondrial myopathies (Suomalainen et al., 
2011). It therefore seems a plausible hypothesis that Fgf21 signaling plays a role in 
neurodegenerative diseases where defects in mitochondrial morphology and function as well as ER 
stress are known to occur. In this context, for instance, it is interesting to note that in AD brains altered 
mitochondrial morphology (Wang et al., 2009) and increased levels of phosphorylated eIF2α (Chang 
et al., 2002) have been reported. In a continuation of our project, we therefore plan to obtain blood and 
CSF samples from AD patients (ethical approval pending) to measure Fgf21 serum levels and to 
correlate those with mitochondrial morphology as well as with the levels of phosphorylated eIF2α 
protein and Fgf21 mRNA. 
 
In summary, we conclude that Drp1 function is pivotal in postmitotic neurons which, however, display a 
remarkable resilience and are able to adapt to blocked mitochondrial fission caused by Drp1 ablation. 
Most surprisingly, these intraneuronal adaptations are communicated to the organism via the catabolic 
cytokine Fgf21 which induces a profound metabolic shift. This work also provides a number of 
suggestions on how to further test and verify our model, and how this could be of clinical relevance. 
The presented results provide a new perspective on the interplay of mitochondria and ER in the 
course of neurodegenerative disease, and will hopefully inspire a new direction of research in the 
scientific mitochondrial community. 
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